Canada @ BIO 2025

BIO International Convention June 16 – 19, 2025 Boston Convention and Exhibition Center

Canada @ BIO 2025

BIO 2025 in Boston was a remarkable moment for Canada’s biotechnology ecosystem, offering a powerful showcase of the sector’s innovation, ambition, and global relevance. With close to 500 Canadian companies attending, over the course of 4 days, the Canada Pavilion stood as a dynamic hub of activity, reflecting the strength of our national ecosystem and the value of pan-Canadian collaboration. With the support of provincial leaders, international partners, and a robust network of Pavilion partners, Canada demonstrated its leadership in advancing biotechnology solutions that matter—especially in areas such as radiopharmaceuticals.

The event also amplified BIOTECanada’s core priorities: a globally competitive investment climate to unlock the full potential of Canadian innovation, and the importance  of a modern regulatory environment. From company milestones and investor engagement to policy dialogue and international collaboration, BIO 2025 affirmed that Canada is not only participating in the global biotech conversation—we’re shaping it.


View All Events

Schedule these dates/times in your calendar, and watch this space for further updates as they become available. All times are Eastern.

Monday June 16

7:009:30am: Alberta Showcase Breakfast: Alberta’s Clinical Trial and Real World Evidence Advantage

Location: Burroughs Room, Westin Boston Seaport

Limited public tickets, Tickets Required for Entry


7:45am: The AI Opportunity: Revolutionizing Clinical Trials, Transforming Healthcare

Location: Westin Boston Seaport District. Grand Ballroom A (Concourse). 425 Summer Street.

Hosted by: Clinical Trials Ontario, Life Sciences Ontario, and OBIO

Description: Explore how artificial intelligence is reshaping clinical trials and the broader healthcare landscape. This event is designed for leaders in the pharmaceutical and medical device industries, CROs, and business and healthcare innovation professionals with a focus on Canada. This networking opportunity highlights the strength of Canada’s research ecosystem and its role in advancing the future of global healthcare. Additional speakers and further details will be announced soon.
To view the invitation, click here.


12:00pm: Exhibition Hall opens


2:00pm: Canada Pavilion Opening 🍁

Location: 🍁 Exhibition Floor (Booth 1038)

Hosted by: BIOTECanada and the Canada Pavilion Partners

Description: Join us alongside distinguished pan-Canadian political leaders as we officially open the Canada Pavilion.


3:00pm: Quebec Pavilion Opening 🍁

Location: 🍁 Exhibition Floor (Booth 1048)


4:00pm – 5:00pm: British Columbia & Atlantic Canada Regional Announcement🍁

Location: 🍁 Exhibition Floor (Booth 1038)

Announcement: SEKISUI DIAGNOSTICS AND THE GOVERNMENT OF PRINCE EDWARD ISLAND ANNOUNCE $16 MILLION INVESTMENT TO EXPAND REAGENT CONTRACT MANUFACTURING CAPABILITIES AT CHARLOTTETOWN FACILITIES. Click to learn more

JUNE 16, 2025 – BOSTON, Massachusetts

SEKISUI Diagnostics and the Government of Prince Edward Island today announced a $16 million (CAD) capital investment in the company’s Charlottetown facilities as part of an ambitious business expansion into contract manufacturing of reagents for global clients.

Premier Lantz announced that the province is contributing $3.9 million in capital investment for the initial facility build-out, repayable on a lease-back arrangement and a labour rebate in support of the Charlottetown expansion.

Sekisui Diagnostics anticipates that the new 22,000 square-foot facility in Charlottetown will be completed by 2026 and will go directly into production for a European customer. Output capacity will triple from 4,500L to 20,000L batch sizes. The expansion will add 25 highly skilled positions to the company’s local workforce of 200 employees.

The Hon. Rob Lantz, Premier of Prince Edward Island and Bob Schruender, President and CEO, SEKISUI Diagnostics shared the podium at the Canada Pavilion during the BIO International 2025 Conference and Exhibition to make the announcement.

“If your medical professional ordered a diagnostic test for you, chances are likely a SEKISUI Diagnostics product made that possible. One of Canada’s best kept secrets is that Prince Edward Island is a leader in our national bioscience ecosystem and has been improving the lives of patients both at home and around the globe for over 50 years,” said Premier Rob Lantz. “Investments, such as what we announced today, are a testament to our province’s enduring commitment to advancing the success of both health innovation and prosperity at home through our highly innovative cluster of bio companies.”

“We are proud that this investment will continue to strengthen our capabilities as we ramp up to break into the market of contract manufacturing on a much larger scale,” shared Bob Schruender, President and CEO SEKISUI Diagnostics. “We thank the Government of Prince Edward Island for their support of this expansion and ongoing belief in both our company and also in the growth of the bioscience sector over many years.”

“We applaud the strength of the private, public partnership that was reflected by today’s announcement,” stated Rory Francis, CEO, PEI BioAlliance. “As a sector we have worked closely with government, industry, and academic partners over the last 20 years to grow

bio-based small and medium-sized enterprises, foster cutting-edge biotechnology, and ultimately enrich the lives of patients and our province.”

Quick Facts:

  • SEKISUI Diagnostic’s product lines include clinical chemistry reagents, i.e. “tests for Cardiac, Liver and general health” point-of-care tests, blood collection tube materials as well as enzymes and specialty biochemicals.
  • As an anchor Prince Edward Island biosciences company Sekisui Diagnostics has had a long-term partnership with the provincial government completing 7 building expansions and over $40 million in capital investment within the last 10 years.
  • This project creates 25 new and highly skilled employment opportunities to the company’s PEI site, recruiting from the local workforce, along with roles specialized for University and College graduates.
  • Construction of the 22,000 square foot facility is expected to be completed in 2026.
  • The bioscience sector in Prince Edward Island grosses over $600 million in revenue annually.

About Sekisui Diagnostics

With over 40 years of experience, SEKISUI Diagnostics’ mission is to enhance life with science and improve the health of all people by supplying innovative medical diagnostics globally to physicians, hospitals, laboratories and alternate testing locations as well as partnerships with the world’s leading healthcare companies supporting accurate and timely patient diagnosis across the globe.


5:00pm – 8:00pm: Networking Event : Rendez-vous Québec

Location: The Exchange, 212, Northern Ave, Boston, MA  02210

Invite only, register by clicking the link below.


6:00pm: Exhibition Hall closes


6:00 – 8:00 PM: Life Sciences BC – Networking Reception

Invite only: Join the waitlist by clicking the link below


Tuesday June 17

7:00am – 9:00am: Canadian Executive Networking Breakfast (For BIOTECanada Members)

Hosted by: BIOTECanada. By invitation only.

Description: BIOTECanada’s breakfast panel at BIO 2025 (Featuring Lana Janes (Abdera), Caroline Barber (Novartis), Paras Sharma (Genesys Capital), Pratibhash (Bosh) Chattopadhyay (AtomVie), moderated by Ritu Banerjee (Assistant Deputy Minister and Interim Head, Health Emergency Readiness Canada, Innovation, Science and Economic Development Canada, Government of Canada)  will explore Canada’s growing strength in radiopharmaceuticals—an area of strategic national value. The event has reached capacity, reflecting the high level of interest in this emerging field.


7:30am – 9:00am: Breakfast and Panel discussion: Get to Know Québec’s RNA Therapeutics Sector

Location: Westin Seaport, 425 Summer St, Otis Room

Public event, register by clicking the link below.


9:00am: Exhibition Hall opens


10:00am – 11:00am: Ontario & Manitoba Regional Announcements 🍁

Location: 🍁 Exhibition Floor (Booth 1038)

Ontario: Shaping the Future of Health: Ontario’s Ecosystem in Action

Description:
Invest Ontario brings together leaders from the province’s world-class life sciences ecosystem to spotlight how Ontario is shaping the future of global health. This session features SickKids, a globally recognized pediatric research hospital, and OmniaBio Inc., a trailblazer in cell and gene therapy manufacturing. Together, they exemplify Ontario’s unique ability to turn scientific breakthroughs into real-world impact. Learn how research excellence, commercial scale-up, and strategic partnerships are positioning Ontario as a destination of choice for next-generation health innovation.


4:00pm – 5:00pm: 2025 Gold Leaf Awards Ceremony 🍁

Location: 🍁 Exhibition Floor (Booth 1038)


6:30pm: Exhibition Hall closes


6:30pm – 8:00pm: Atlantic Canada International Networking Reception

Hosted by: Atlantic Canada BioIndustries
Location: Boston Tea Party Museum: 306 Congress St, Boston, MA 02210
By invitation only.
Contact: Bobbi Jo Walker: bobbijo@peibioalliance.com


8pm10pm: Alberta@BIO Reception

Location: Harpoon Brewer & Beer Hall, Boston

Public, Tickets Required for Entry

Wednesday June 18

9:00am: Exhibition Hall opens


10:00am – 11:00am: Coast-to-Coast Competition: A company pitch event 🍁

Location: 🍁 Canada Pavilion Exhibition Floor (Booth 1038)

Hosted by: BIOTECanada and Mintz

Description: Meet the 2025 BIOTECanada Coast-to-Coast Competition presenters: 48Hour Discovery, Rhythm Biotherapeutics, Stereo Biotherapeutics, HTuO Biosciences, and Theranib who will deliver a brief pitch, without slides, to the audience and panel of judges. The winner will receive an invitation to attend BIOTECanada’s Investment Summit in March 2026.


1:00pm – 2:30pm: Reverse Pitches & Networking Event for Canadian Delegates

Location: Aloft Hotel – Mann 3 Ballroom – 401-403 D St. Boston (across the street from the Convention Centre)

Hosted by: Canadian Consulate in Boston

Description: Join us to meet and network with BD team members from leading companies and organizations in a casual environment.  Participating companies looking to meet with Canadian companies and discuss their areas of interest and get connected with Canadian companies include Merck, Bayer, AstraZeneca, Moderna, CSL Behring, Amgen, Eli Lilly, Acadia Pharma, Organon and others.


6:00pm: Exhibition Hall closes

Thursday June 19

9:00am: Exhibition Hall opens


4:30pm: Exhibition Hall closes


4:30 PM – 9:00PM: International BIO Night!

Location: CIC Cambridge, One Broadway, Cambridge, MA 02142

Hosted by: Venture Café – CANADA will be a featured country at the event!

Description: Join us for a night of global discovery at Venture Café’s International Biotech Showcase, where innovation knows no borders! From interactive startup demos to a powerhouse panel on the future of biotech (featuring Rodrigo Arancibia from ISED), this evening brings together trailblazing founders and thought leaders from the UK, Canada, Finland, South Korea, and beyond. Venture Café gatherings typically see 300-400+ attendees, so a great opportunity for networking. Open to all!



Let’s show Canada’s presence at BIO 2025!

BIOTECanada has created shareable social media graphics for your use, they are designed to highlight your participation at BIO, and amplify Canada’s role on the global biotech stage.

How to get started: let your network know you’ll be at BIO 2025!

1. Click on the image you want to download

2. On your own LinkedIn feed, create a post as you normally would, upload your image, and post!

3. Don’t forget to use the hashtags: #CanadaAtBIO #BIO2025, and tag our account: @Biotecanada

BIO Exhibition Map

Click the map to view the fully interactive view. The Canada booth is featured at location 1038

Useful Information

🚌Getting around BIO just got easier.🚌
The official BIO shuttle schedule is here.

Follow our LinkedIn page for the latest on BIO 2025 and updates from across Canada’s biotech ecosystem: @BIOTECanada

Canada @ BIO Newsletter

📢 Stay Informed, Stay Connected! 📢

Sign up for the Canada @ BIO Newsletter to stay updated on all Canadian activities happening in Boston. Get exclusive insights, key event highlights, and networking opportunities—delivered straight to your inbox!

Hosting an event in Boston? Let us know at info@biotech.ca

2025 BIO Newsletters

Ensure you’re on our mailing list to receive the BIO Newsletter.

🔗 Subscribe now and stay ahead!

Name(Required)
This field is for validation purposes and should be left unchanged.

From Prep to Partnership: A Guide to BIO 2025 Meetings

Learn More

In this webinar, industry panelists will share real-world advice from their BIO experiences, highlighting strategies that work, what to avoid, and how to position yourself for success. You’ll learn how to build a standout BIO Partnering™ profile, identify the right partners, craft compelling meeting requests, and maximize your time onsite. Plus, get the latest updates on networking events and follow-up strategies for lasting impact.

BIO 2025 Program Tour and Preview of New Features

Learn More

Hear about this year’s featured sessions and notable expert speakers. This webinar will be your first look at several new program session types and event surprises in progress, including a BIO Storytelling Stage, new evening reception venues, and an expanded main stage experience that will debut this year.

An Introduction to BIO Partnering™ and Key Strategies for Success at the BIO International Convention

Learn More

Join BIO’s VP of Partnering, Mackensie Vernetti, for a webinar showcasing the new platform, complete with an in-depth live demo, as well as partnering tips and best practices. This webinar will provide the tools and guidance to maximize your experience at the event.

Discounted Premier Access passes for BIOTECanada members are SOLD OUT!

Heading to Boston? Use the discount code below for flight discounts.

Click for more details – Air Canada: UQR9T821
  • The booking is to be made to the following city: Boston, BOS (US)
  • The travel period begins Monday, June 09, 2025 and ends Thursday, June 26, 2025.
  • Travel is valid Monday, Tuesday, Wednesday, Thursday, Friday, Saturday, Sunday.
  • For North America’ 5% applies on standard fares, 10% on flex fares & higher. For International Travel’ 10% on standard fares & higher.
Click for more details – Porter Airlines: BIOC25

Porter Airlines is proud to offer a up to 10% discount on available base fares (with the exception of the lowest class fare during a public seat sale) for travel to and from BIO International Convention 2025 . The discounted fares are available for booking from July 12, 2024 to June 15, 2025 and available for travel:

  • From: All Markets To: Boston (BOS)From:June 13 To: June 17
  • From: Boston (BOS) To: All Markets From: June 18 To: June 21

Please book online at https://www.flyporter.com/en-ca/?promocode=BIOC25 or through your travel agent using promo code “BIOC25”

Highlights from the Canada Pavilion at BIO 2024

BIO 2025 Canadian Delegation Directory

Are you a Canadian biotech company heading to BIO 2025? Make sure you’re seen!

Submit your information through our official web form to be included in the Canadian Delegation Directory—the go-to resource for delegates looking to connect with Canada’s biotech leaders.

This live, searchable directory is featured on an interactive touch-screen in the heart of the Canada Pavilion, and published on our website where it’s continuously updated before and throughout the event.

Company Location Primary Segment Website Email Description
20/20 Optim EyesHamilton, ONDrug, Therapeutic2020opitmeyes.cafrances@2020optimeyes.ca20/20 OptimEyes Technologies has developed a mucoadhesive drug delivery platform technology that allows for improved solubility of APIs and extended release. Validated as an eye drop, with successful pre-clinical studies in glaucoma, dry eye and uveitis, 20/20 OptimEyes is seeking partners to further develop these assets or those with novel or repurposed APIs targeting mucosal areas for co-development opportunities.
2300EstimauvilleSaint-Hubert, QChttps://www.harveycorp.ca/en/We specialize in the management and development of real estate projects. Our activities are mainly concentrated in the industrial, commercial and office real estate sectors, but also in the fields of energy and construction. We have developed great expertise in the construction and conversion of buildings into laboratory spaces dedicated to life sciences
35PharmaMontreal, QCDrug, Therapeutic35pharma.com35Pharma is a biopharmaceutical company that rationally designs and develops innovative biologics with best-in-class potential for cardiopulmonary diseases and obesity / T2D.
3D BioFibR Inc.Halifax, NS3dbiofibr.comksullivan@3dbiofibr.comFor decades, industry has tried to reassemble collagen back into fibers that match collagen fibers in the body. 3D BioFibR's patented dry spinning has solved this challenge with control over length, orientation and scale of collagen fiber production.
3Sixty Public Affairs.Inc.Ottawa, ONhttps://3sixtypublicaffairs.com/3Sixty Public Affairs is a government relations and public policy consulting firm serving the health and life sciences sectors. We help create bridges between governments, businesses and civil society. 3Sixty provides clients with government relations strategies, public affairs engagement training and workshops and research and analysis.
48Hour DiscoveryEdmonton, AB48hourdiscovery.comrfinnegan@48hourdiscovery.comAt 48Hour Discovery, we’re on a mission to revolutionize drug discovery in the field of peptides. We believe in pushing the boundaries of what’s possible, exploring new frontiers, and leveraging cutting-edge technology to drive breakthroughs in medicine. Our team is a dynamic blend of scientific innovators, visionary leaders, and dedicated professionals working collaboratively to develop life-changing therapeutics.
5 Prime Sciences Inc.Montreal, QC5prime.com5Prime Sciences uses genomics and other -omics to accelerate drug development by selecting targets that cause human disease and identifying the right patients for clinical trials
88 GOToronto, ONhttps://www.88go.ca/index.html88 GO Inc. is an entrepreneur-led firm based in Toronto, Canada, dedicated to accelerating innovation in the healthcare and life sciences sectors. Our mission is to empower visionary entrepreneurs by providing the resources, expertise, and strategic guidance needed to scale proven businesses and drive transformative growth.
9 BIO TherapeuticsQuebec City, QCBiotech & Pharma - 2https://9bio.ca/decarvalho@9bio.ca9Bio stands at the confluence of biology, structural engineering, and artificial intelligence, pioneering breakthroughs that will shape tomorrow’s healthcare. We’re engineering previously unimaginable biological possibilities.
AbbVie CanadaMarkham, ONabbvie.comlynda.ravlich@abbvie.comWe’re a company that takes on the toughest health challenges. But we do more than treat diseases—we aim to make a remarkable impact on people’s lives. We are AbbVie, a highly focused research-driven biopharmaceutical company.
AbCelleraVancouver, BCDrug, Therapeuticabcellera.comAbCellera (Nasdaq: ABCL) discovers and develops antibody medicines for indications across therapeutic areas including cancer, metabolic and endocrine conditions, and autoimmune disorders. AbCellera’s engine integrates technology, data science, infrastructure, and interdisciplinary teams to solve the most challenging antibody discovery problems. AbCellera is focused on advancing an internal pipeline of first-in-class and best-in-class programs and collaborating on innovative drug development programs with partners.
Ability BiotherapeuticsMontreal, QChttps://www.ability.bio/en/Develop innovative, targeted, immune modulating biotherapeutics to address unmet medical needs in patients with cancer and autoimmune diseases.
Acanthus Pharma Services Inc.Hamilton, ONhttps://acanthuspharma.com/Welcome to APS Pharma., a tenacious innovation driven company specializing in simplifying preclinical and early clinical drug development. Established in 2021 in the suburban Toronto metropolitan area by industry professionals with a proven track record of successful introduction of new molecular entities into pre-clinical and clinical lifecycle phases. Our founders envisioned a company focused on customized synthetic and process chemistry solutions and Good Manufacturing Practices (GMP) manufacturing.
ACIC Pharmaceuticals IncBrantford, ONhttps://acic.com/ACIC provides clients and partners with active pharmaceutical ingredients (API’s), finished dosage forms, injectables, contract manufacturing services, process development and optimization, regulatory services, clinical services from cGMP and FDA inspected facilities. ACIC and our clients and partners have established a tremendous reputation and are recognized for high quality products and performance efficacy.
ACOA PEI & TourismCharlottetown, PEhttps://meetpei.com/Whether you’ve visited Prince Edward Island every summer since you were 9-years-old or have only seen photos on travel blogs, chances are you already know there’s something magical about it. Because very few other places in the world offer this unique blend of stunning seascapes and fishing villages, wind-swept fields and friendly people, charming cities and historic landmarks. Located just off the east coast of Canada, our small island awakens the senses and acts as the perfect backdrop to bring people together to learn, connect and explore.
Acuitas Therapeutics, Inc.Vancouver, BCDrug, TherapeuticDrug, Therapeuticacuitastx.combd@acuitastx.comVancouver-based Acuitas Therapeutics, Inc. is a globally recognized private biotechnology company specializing in the development of delivery systems for nucleic acid therapeutics based on lipid nanoparticles.
ADEPT - The Alberta Diagnostics Ecosystem Platform for TranslationEdmonton, ABalbertalabdiagnostics.cajreid3@ualberta.caAlberta's diagnostics technology innovation and translation capacity is internationally competitive, produces high value products and services, attracts key investments that build our economy, and improves the lives of Albertan's and patients everywhere.
adMare BioInnovationsVancouver, Toronto, Montreal, BC, ON, QCDrug, Therapeuticadmarebio.comflemaitreauger@admarebio.comWith a strong track record of globally-competitive scientific discovery, Canadian life sciences are primed to lead the world. To make this a reality, adMare BioInnovations uses its scientific and commercial expertise, specialized R&D infrastructure, and seed capital to build strong life sciences companies, develop robust ecosystems, and foster industry-ready talent. It re-invests its returns into the Canadian industry to ensure its long-term sustainability. adMare currently has 29 portfolio companies that have attracted $2.3 billion of risk capital, have a combined value of more than $4 billion, and have created over 1,000 jobs in Canada.
Aird & McBurney LPToronto, ONServices: Legal, Consulting, Businessairdmcburney.comksinden@airdmcburney.comProviding intellectual property services to the life sciences community, including IP strategy, patent preparation and prosecution, patent portfolio management, IP due diligence and freedom to operate analyses.
Alberta Cancer FoundationEdmonton & Calgary, ABalbertacancer.cachristy.holtby@albertacancer.caOne in two Albertans will be diagnosed with cancer. These are our loved ones, our friends, our neighbours. In partnership with the brightest minds, and with compassionate care, the Alberta Cancer Foundation is making life better for Albertans facing cancer. We are the official fundraising partner for every Alberta Health Services cancer centre in Alberta. ; Our very purpose comes from our desire to create more moments for all Albertans facing cancer, no matter where they live or the type of cancer they are facing. We do this by supporting world-class research and patient care, close to home.;
Alberta Health ServicesEdmonton, ABhttps://www.albertahealthservices.ca/default.aspxOur work takes place on historical and contemporary Indigenous lands, including the territories of Treaty 6, Treaty 7 & Treaty 8 and the homeland of the Mtis Nation of Alberta and 8 Mtis Settlements. We also acknowledge the many Indigenous communities that have been forged in urban centres across Alberta.
Alberta InnovatesEdmonton, ABalbertainnovates.caTim.Murphy@albertainnovates.ca, Ryan.Mercer@albertainnovates.caAlberta Innovates provides funding, business advice and connections, applied research and industrial testing facilities to accelerate research and innovations that benefit Albertans.
Alberta Real World Evidence ConsortiumEdmonton, ABalbertarwe.camartinuk@ualberta.caThe province of Alberta stands out as a global leader in real-world health system data, housing one of Canada’s largest, most mature, and comprehensive repositories. This remarkable resource serves as the foundation for the Alberta Real World Evidence Consortium, a highly experienced cross-functional provincial research team from the Universities of Alberta and Calgary, along with the Institute of Health Economics. Leveraging these unique data assets, the Consortium conducts timely health-focused research using real-world data, engaging funding partners, decision-makers, and knowledge users.
Alexion (AstraZeneca rare)Mississauga, ONBiotech& Pharmahttps://alexion.com/worldwide/Canadaphilippe.renaud@alexion.comAlexion, AstraZeneca Rare Disease, is focused on serving patients and families affected by rare diseases and devastating conditions through the discovery, development and delivery of life-changing medicines.
Allarta Life Science Inc.Humilton, ONDrug, Therapeutic,Diagnostics, Devicewww.allarta.comJake@allarta.comPlatform to delivery allogeneic cells without immune suppression. First indication cell therapy for T1D.
allianceboardTrois-Rivieres, QChttps://www.allianceboard.com/
Allumiqs CorporationHalifax, NSallumiqs.comkmaclean@allumiqs.conAllumiqs is a Contract Research Organization (CRO) delivering solutions that help biotech and biopharma companies accelerate their innovations from discovery to patient value.
Alpha Cognition, IncVancouver, BCDrug, Therapeuticalphacognition.comInfo@alphacognition.comAlpha Cognition is a clinical stage, biopharmaceutical company dedicated to developing treatments for under-served neurodegenerative diseases such as Alzheimer's Dementia and Amyotrophic Lateral Sclerosis (ALS).
Alpha-9 Oncology, Inc.Vancouver, BCBiotechnology, Diagnostics, Medical Technology , Therapeutics www.alpha9tx.com info@alpha9tx.comAlpha-9 Oncology is a clinical-stage biopharmaceutical company founded in 2019 by renowned scientists based at BC Cancer and the University of British Columbia.The Company is using its world-class know-how in molecular design and targeting of radiotherapeutics to advance a portfolio of breakthrough technologies focused on the precision targeting of metastatic cancer. These technologies promise to potentially revolutionize the way in which metastatic cancer is both diagnosed and treated.
AltasciencesMontreal, QChttps://www.altasciences.com/Altasciences is a forward-thinking, mid-size contract research organization offering pharmaceutical and biotechnology companies a proven, flexible approach to preclinical and clinical pharmacology studies, including formulation, manufacturing, and analytical services.
Altis Labs, Inc.Toronto, ONaltislabs.comduoaud@altislabs.comForemost, our priority is to improve patients outcomes by helping our partners raise the standard of care.
Altus Formulation Inc.Laval, QCaltusdrugdevelopment.comdamonsmith@altusformulation.comAltus is a specialty pharmaceutical company that designs, develops and delivers patented value-added new medicines in the CNS segment backed by robust patents.
AmacaTheraToronto, ONDrug, Therapeuticamacathera.camikejcooke@amacathera.caAmacaThera, a clinical-stage company developing therapeutics based on our unique long-acting injectable platform (AmacaGel) for localized sustained delivery of small molecules and/or biologics to improve patient outcomes.
AmorChemMontreal, QChttps://amorchem.com/info@amorchem.comAmorChem is a leading early stage venture fund dedicated to creating the next generation of biotech companies from academic research.
AmorChem VenturesMontreal, QCInvestoramorchem.comkevin@amorchem.comAmorChem II (www.amorchem.com) is a leading VC fund focused on investing in promising life science projects from research-stage to preclinical proof-of-concept, after which we seed newcos and develop technologies to facilitate a Series A financing round
Amp HealthSt. John's, NLDigital Healthamphealth.camandy@amphealth.caAt Amp Health we’re on a mission to help millions of people prevent type 2 diabetes, as the catalyst to keeping blood sugar in range via behaviour change. We pair our novel behavior change models with user data to create interventions when glucose spikes are detected, pairing alerts with actionable steps that a user can take to drastically reduce the impact of blood glucose on their body and reduce pre-diabetes. We're launching pilots in Fall 2024 and raising a pre-seed round - and we’d love to tell you more about how we’re going to reach this massive and growing market to change the future of disease prevention.
Amplitude VenturesCalgary, ABamplitudevc.comnlachman@amplitudevc.comOur current investment focus is on precision medicine where world-class innovators are driving the future of healthcare
Ananda Devices - Business ForumMontreal, QCanandadevices.comdoreen@anandadevices.comAnanda Devices is a Canadian neuroscience technology company that specialize in developing and commercializing nervous systems and other innervated tissue on-a-chip platforms to accelerate drug discovery processes
Antibe Therapeutics IncToronto, ONDrug, Therapeuticantibethera.cominfo@antibethera.comAntibe is a clinical-stage biotechnology company leveraging its proprietary hydrogen sulfide platform to develop next-generation safer therapies to target inflammation arising from a wide range of medical conditions.
ApobiologixToronto, ONDrug, Therapeuticwww1.apotex.combd2@apotex.comApobiologix is a division of Apotex Inc., Canada's leading manufacturer of generic & biosimilar medicines. Our focus is the commercialization of biosimilars & differentiated small molecules delivering quality and value for patients and healthcare systems.
Apotex CorporationToronto, ONDrug, Therapeuticapotex.comApotex Inc. is a Canadian-based global health company that produces high-quality, affordable and complex medicines for patients around the world, with a strategic focus on becoming a Canadian Health Champion and an Americas Partner of Choice.
Applied Pharmaceutical Innovation (API)Edmonton, AB Services: Contract Research, Development, Manufacturingappliedpharma.cashawn.couch@appliedpharma.caAPI, one of Canada's largest not-for-profit life sciences organizations, bridges the gap between academic research, development and commercialization. Enabling innovation among life sciences academia, startups and small to medium-sized enterprises, API provides direct access to industry capacity and expertise, accelerating testing and development timelines.
Aramis BiotechnologiesQuebec City, QCBiotech& Pharmawww.aramisbiotechnologies.comncharland@aramisbiotechnologies.com, fors@aramisbiotechnologies.comAramis Biotechnologies is a company specializing in plant-based production of innovative vaccines and biotherapeutics. Aramis’ ambition is to develop innovative and sustainable solutions to current and future public health challenges.?
ARC Medical Inc.Richmond, BCDiagnostics, Devicearcmedinc.comcspringate@arcmedinc.comARC has the only liquid medical devices that flow, form a temporary barrier film, and prevent surgical adhesions throughout the entire surgical area.Surgeries include gynecological (women's health), abdominal, and orthopedic (knee, shoulder, hip FAI),
Aspect BiosystemsVancouver, BCDrug, TherapeuticDrug, Therapeuticaspectbiosystems.comAspect is pioneering the development of bioprinted tissue therapeutics to transform the treatment of currently incurable diseases. These next-generation cell therapies are designed to replace, repair, or supplement biological function inside the body. The company’s current therapeutic pipeline is focused on metabolic and endocrine diseases such as diabetes, obesity, and congenital liver disorders.
AstraZenecaMississauga, ONhttps://www.astrazeneca.ca/frpatrick.bergeron@astrazeneca.comWe work to research, develop and market innovative medicines. AstraZeneca Canada was recently designated a global Clinical Hub for oncology and immuno-oncology clinical studies. We are currently leading global oncology clinical studies in lung, head, and neck cancer.?
Atheris LaboratoriesToronto, ONhttps://atherisgroup.com/At Atheris, we are more than consultants—we are partners in your journey to transform challenges into opportunities. Born from a passion for advancing science and healthcare, we bring together a team of seasoned experts and an extensive network of professionals dedicated to empowering innovation and driving excellence. Our values are rooted in collaboration, integrity, and impact.
Atlantic Canada Bio-Industries AllianceCharlottetown, PIhttps://www.atlanticbio.ca/The Atlantic Canada Bio Industries Alliance is an umbrella organization representing bio industry associations in the four Atlantic provinces: New Brunswick, Newfoundland and Labrador, Nova Scotia, and Prince Edward Island.
AtomVie Global RadiopharmaHamilton, ONhttps://www.atomvie.com/AtomVie is a global leader in the radiopharmaceutical industry dedicated to transforming patients' lives by advancing high quality drugs for the diagnosis and treatment of diseases.
Atuka Inc.Toronto, ONDrug, Therapeutichttps://atuka.com/
Augurex Life Sciences Corp.Vancouver, BChttps://augurex.com/Augurex is a a commercial stage diagnostics company focused on novel autoimmune solutions. JOINTstat® (14-3-3eta for RA) is a best-in-class diagnostic test for the diagnosis, prognosis and monitoring of Rheumatoid Arthritis, SPINEstat® is a first-in-class diagnostic test for Axial Spondyloarthritis.
AvantorMISSISSAUGA, ONDrug, Therapeuticavantorsciences.comjeff.vallerga@avantorsciences.comAvantor® is a leading life science tools company and global provider of mission-critical products and services to the life sciences and advanced technology industries. We work side-by-side with customers at every step of the scientific journey to enable breakthroughs in medicine, healthcare, and technology. Our portfolio is used in virtually every stage of the most important research, development and production activities at more than 300,000 customer locations in 180 countries.
AVIR Pharma Inc.Blainville, QCDrug, Therapeuticavirpharma.comcontact@avirpharma.comAVIR Pharma is a commercial stage speciality pharmaceutical company focused on the commercialization of innovative brand medicines for the Canadian marketplace.
AxCell LabsSherbrooke, QChttps://axcell-labs.com/en/home/AxCell Labs is a biotechnology company specializing in the production of bacterial cellulose for the medical industry. Founded in 2021, our team focuses on the design and development of implants in membrane or injectable form with the aim of stimulating the formation of new soft tissue required in several reconstructive surgeries.
AxelysMontreal, QCSupport Orgs and Associationshttps://www.axelys.ca/en/Kimiaka.guerard@axelys.caAxelys is a non-profit organization whose mission is to contribute to the economic and social prosperity of Quebec by accelerating the development and transfer of high-potential innovations stemming from public research.
AXS StudioToronto, ONhttps://axs3d.com/We’re a team of medical writers, certified medical illustrators, scientifically-trained animators, interactive developers, designers and producers. Together, we create visual experiences to tell science stories and make meaningful impact.
B3 PharmaQCB3-Pharma is a platform biotechnology company focused on developing drug conjugates using its “plug-and-play” Angiopep peptide technology\ capable of transporting large and small molecules across the BBB with its lead program in oncology in Phase 3.
Badalone ConsultingSaint Lazare, QCvbadalone@videotron.caWe have a unique business model that combines an investment arm, scientific support in the non-clinical and clinical spaces, and a semi-virtual outsourcing platform for minimal overhead costs and enables project investment to occur “incrementally” as need
Balandina
BanookMontreal, QCbanookgroup.comrola.hamed@banookgroup.comBanook Group is a global provider of cardiac, imaging, and endpoint adjudication central services to the pharmaceutical, biotechnology, and medical device industries.
Bausch Health, CanadaLaval, QCBiotech& Pharmahttps://bauschhealth.ca/martin.barbeau@bauschhealth.comAn innovative company dedicated to advancing Canadians’ health and health care. Part of a major global company headquartered in Laval, Québec, with products available in 75 countries.?Pharmaceutical manufacturing in Steinbach, MB and Laval, QC. These two plants manufacture more than 300 pharmaceutical products.
Bayshore Specialty RxMississauga, ONServices: Contract Research, Development, Manufacturingbayshore.cabgood@bayshore.cahealth care service provider: 3PL, wholesale, home nursing, specialty pharmacy, patient support services
BC Public ServiceVancouver, BChttps://www2.gov.bc.caAcross British Columbia, dedicated individuals make valuable contributions every day to provide outstanding service to the people of our province. When you put your ideas to work with us, you'll have access to a range of career options and unique benefits and experiences that you will not find anywhere else.
BCF LLPMontreal, QCServices: Legal, Consulting, Businessbcf.caEmma.saffman@Bcf.caLegal services
BDO CanadaCanadahttps://www.bdo.ca/At BDO, we are constantly evaluating new trends in the market that are likely to impact our clients in the short, medium, and long term. In turn, we are making proactive investments in innovation initiatives that have the potential to offer our clients a sustainable competitive advantage.
BDO LLPhttps://www.bdo.ca/
Benoît & CôtéExperienced, professional triathlon coach helping athletes reach their goals
Bereskin & Parr LLPToronto, ONServices: Legal, Consulting, Businessbereskinparr.comAs one of the largest and top-rated intellectual property law firms in Canada, Bereskin & Parr specializes in intellectual property law across twenty-six industry practice areas. We are your partners in brilliance, here to provide solutions that safeguard the value of ideas to help businesses today, and tomorrow. Bereskin & Parr’s Life Sciences practice group is comprised of professionals with diverse technical backgrounds and industry expertise, ensuring members stay at the forefront of trends in the ever-changing industry, and in the law that relates to it.
BioAlbertaEdmonton, ABNon-Profit, Industry Association, Incubatorbioalberta.comadmin@bioalberta.comBioAlberta is the voice and champion for the life sciences and health innovation industry in Alberta. We promote, advocate and proactively facilitate the growth of Alberta’s life sciences industry.
BioAroCalgary, ABbioaro.comronak@bioaro.comBioAro has launched over 300 Disease Based DNA Panels, WGS/WES/MicroBiome Cancer Sequencing, and in 2024 it will be launching Liquid Biopsy based Cancer Screening Test of over 100 common cancers. It is building State of the Art AI Powered Analytics Platforms (www.BioAro.com) and Canada's Biggest Genomic Lab. It is investing in the field of Epigenetics and collaborating with academic institutions. It also plans to launch its animal, agriculture and food sequencing division in the future.
BioCanRxOttawa, ONNon-Profit, Industry Association, Incubatorbiocanrx.comsmichaud@biocanrx.coThe BioCanRx vision is to turn all cancers into curable diseases. We invest in leading edge immune oncology research translating world-class technologies from the lab into early phase clinical trials. BioCanRx provides researchers with access to funding,
Biocon Biologics Canada IncToronto, ONDrug, TherapeuticBioconBiologics.comBiocon Biologics Canada Inc. is the Canadian subsidiary of Biocon Biologics Ltd., a fully integrated global biosimilars company dedicated to expanding access to high-quality, affordable biologic therapies. With a presence in over 120 countries, Biocon Biologics focuses on therapeutic areas such as oncology, diabetes, immunology, and ophthalmology, offering biosimilars including trastuzumab, pegfilgrastim, insulin glargine, and aflibercept. The company is committed to supporting Canadas healthcare system through cost-effective treatments and partnerships that promote health equity and sustainability.
Biocon Biologics Ltd.Toronto, ONhttps://www.bioconbiologics.com/We specialize in the following modalities and substances, mammalian and microbial-based therapeutic proteins, plasmid DNA (pDNA), messenger RNA (mRNA), viral vectors, and genetically engineered cells. Our services range from process development, analytical development, cGMP manufacturing, quality control and quality assurance, and process validation.
BioContact QuébecMontreal, QChttps://www.newswire.ca/news/biocontact-quebec/
Biodextris RNA IncLaval, QCPartners for your drug discovert, pre-clinical and clinical phaseBiodextris.comcedric.heroux@biodextris.comTrusted CDMO partner with decades of experience, Biodextris helps clients – from start-ups to big pharma – to develop, manufacture and test a wide range of complex biological products. Whether it be vaccines, biologics, or other large molecule products, we will help you bring your product to life.
BioHarvest SciencesVancouver, BChttps://bioharvest.com/Bioharvest Sciences is a global leader in plant cell biology leveraging its patented technology platform called Botanical Synthesis to grow life-changing plant-based molecules at the greatest levels of industrial scale to deliver the next generation of science-based and clinically proven therapeutic solutions without having to grow the plant itself. BioHarvest is achieving this vision via its Contract Development and Manufacturing Organization that develops unique plant derived compounds for major customers in the pharmaceutical, cosmetic and nutrition industries and through its own D2C Health and Wellness Business.
Biologics Manufacturing CenterMontreal, QCbmc-cppb.caleila.sabouri@bmc-cppb.caThe Biologics Manufacturing Centre (BMC) Inc. is an end-to-end GMP biomanufacturing facility, supporting the growth of domestic biomanufacturing production capacity, ensuring that vaccines and other biologics can be safely manufactured in Canada.
BIOQuébecLaval, QCSupport Orgs and Associationshttps://www.bioquebec.com/jburkhard@bioquebec.com, blarose@bioquebec.comBIOQuébec is a non-profit association, fully funded by its members. It currently represents over 270 companies and organizations in Quebec working in the life sciences and health technologies industry. Our members are involved at every stage of the health innovation chain and contribute significantly to improving the quality of life of citizens. Their activities include the discovery of medicines, vaccines, and diagnostic tools, as well as their development, manufacturing, and commercialization.
Bioscience Association ManitobaWinnipeg , MBNon-Profit, Industry Association, Incubatorwww.biomb.caandrea.ladouceur@biomb.ca,janelle@biomb.caBioscience Association Manitoba (BAM) is here to support Manitobas Bioscience sector. With over 200 members and companies in health, agriculture, and clean biotechnology. Were dedicated to helping our industry grow through advocacy, workforce development, promotion, and meaningful connections. Manitoba is a remarkable centre of discovery. When you delve into the synergies among biotechnology, agriculture, and biosciences, youll understand why we have a thriving bioscience sector from idea to research to commercialization.
BioScript SolutionsOakville, ONDrug, Therapeuticstarantino@bioscript.caFrom Importation to Patient, BioScript supports a broad range of complex drug therapies and delivers full-service solutions for specialty care — from our patient support programs, wholesale pharmaceutical distribution and third-party logistics to our clinics and pharmacies that serve thousands of Canadians coast to coast every year.
BIOScript/ACCELERAOakville, ONDrug, Therapeuticaccelerapharma.comstarantino@apcipharma.comSince 2001, BioScript Solutions has supported patients with chronic illnesses and rare diseases by providing access to complex drug therapies and delivering full-service specialty care solutions at every stage of their treatment journey. BioScript Solutions is committed to helping patients with chronic illnesses achieve the best possible health outcomes. With its total care approach, BioScript Solutions simplifies access to complex drug therapies and deliver full-service specialty care solutions at every stage of the patients’ treatment journey ? from its third party logistics (3PL) and wholesale distribution to our patient support programs, clinics and pharmacies that serve thousands of Canadians coast-to-coast every year. BioScript Solutions is partnered with Accelera Canada; together they are Canada's agile end-to-end commercialization specialists for innovative life science products and are your one-stop, go-to-market resource in Canada.
BioSyentMississauga, ONDrug, Therapeuticbiosyent.cominfo@biosyent.comBioSyent Inc is a profitable, growth-oriented, publicly listed Canadian Specialty Pharmaceutical company based in Toronto that sources, acquires/in-licenses and markets pharmaceutical products in Canada and in International markets.
BioSymetrics (Renovaro)Toronto, ONhttps://www.biosymetrics.com/BioSymetrics is a phenomics-driven drug discovery company that integrates clinical and experimental data, using machine learning, to translate human disease biology and advance precision medicines. Elion, the BioSymetrics platform, uses machine learning to connect data sources – including patient data from millions of electronic medical records and experimental data captured in zebrafish models using proprietary computer vision – to identify high-confidence targets for drug discovery. Targets discovered using BioSymetrics’ platform are grounded in human genetic evidence, giving them twice the likelihood of clinical success. BioSymetrics is advancing programs in cardiometabolic, neurological, and rare diseases, including familial dilated cardiomyopathy, atherosclerosis, and epilepsy.
BioSyntech Inc.QCBiotechnologyBioSyntech was a medical device company specialized in the development, manufacturing and commercialization of advanced biotherapeutic thermogels for regenerative medicine (tissue repair) and therapeutic delivery. BioSyntechs platform technology is a family of hydrogels called BST-Gel.
BIOSYNTHhttps://www.biosynth.com/Biosynth is?an innovative life sciences reagents, custom synthesis and manufacturing services company. We are by scientists, for scientists, securing supply chains with consistent quality, across the globe.?We manufacture and source a vast range of chemical and biochemical products, and take pride in delivering products that others cannot.
BioTalent CanadaOttawa, ONNon-Profit, Industry Association, Incubatorbiotalent.caoperations@biotalent.caBioTalent Canada is a labor market research organization that bridges the gap between academia and the biotech industry through its products and services.
BIOTECanadaOttawa, ONNon-Profit, Industry Association, Incubatorbiotecanada.ca/eninfo@biotech.caBIOTECanada is the national industry association with over 200 members located nation wide, reflecting the diverse nature of Canada's health, industrial and agricultural biotechnology sectors.
Biotech City - LavalLaval, QCNon-Profit, Industry Association, Incubatorcitebiotech.comjmjuteau@citebiotech.comThe Biotech City is a life science hub in the Metropolitan Montreal including 120 companies, a research institute, a startup incubator employing more than 5,500 highly skilled people.
BioTraceITCharlottetown, PEpaintrace.cominfo@biotraceit.comPrescriptive medicine through individual outcomes. PainTrace® is individual objective, actionable real-time, acute and chronic pain responses. Quantify pain during examination, surgery, or over time in response to treatment. POC or remote.
BioVectraCharlottetown, PEbiovectra.cominfo@biovectra.comBioVectra is a global CDMO serving pharmaceutical, biotech, and gene therapy companies with full-service cGMP outsourcing solutions for intermediates, APIs, Drugs Substances and Drug Products. We operate out of 5 cGMP facilities located in North America.
Biron Groupe SantéBrossard, QCPre clinicalhttps://www.biron.com/fr/juarcand@biron.com, jgbouchard@biron.comBiron, founded in 1952, is a leading healthcare provider in Quebec, offering expert, human-centered services in laboratory, imaging, genetics, sleep care, and occupational health
Blake, Cassels & Graydon LLPCalgary, Montreal, Ottawa, Toronto, VancouverServices: Legal, Consulting, Businessblakes.comjoseph.garcia@blakes.comBlakes is a leading Canadian law firm with a long history of representing pioneers and leaders in the life sciences industry. We advise Canadian and foreign companies operating in Canada on domestic and cross border business activities. Clients look to us for the full range of legal services to address their complex business needs including commercialization, regulatory, private finance, capital markets and M&A.
BLG LLP - Intrinsik Corp.Ottawa, ONhttps://www.bio.org/he biotechnology industry is a critical national security asset. We must consider how to prepare for future pandemics and respond to potential bioterror attacks. Resilience and the ability to safeguard public health in extreme circumstances are paramount. Ensuring a vibrant public health system demonstrates the benefits of a free and democratic society. Collaboratively, entrepreneurs and companies can not only serve U.S. citizens and allies, but also benefit the entire globe.
Bora Biologics and Bora PharmaceuticalsMississauga, ONhttps://www.borabiologics.com/Unlock the Future of Biologics with Bora Biologics Discover how our advanced technologies can accelerate your projects from concept to commercialization. As a leading CDMO, we offer: End-to-End Solutions: Comprehensive early-phase development and late-stage manufacturing.Proven Track Record: Over 45 biologics developed and 100+ successful cGMP batches.Integrated Fill/Finish Services: Streamlined solutions for vials and pre-filled syringes.Why Partner with Us? Leverage our state-of-the-art facilities and a highly qualified team of experts dedicated to delivering high-quality results. Our client-centric approach ensures tailored solutions that align with your specific goals.Connect with our experts to explore collaboration opportunities and learn how we can support your biologics projects and enhance market entry.
Borden Ladner Gervais LLPOttawa, Toronto,Montreal,Vancouver, ON,QC,BCService:Legal,Consulting,Business Investorwww.blg.comkpejemsky@blg.comAs the largest Canadian law firm, BLG delivers practical legal advice for domestic and international clients. BLG serves the legal needs of businesses and institutions from M&A to disputes, financing, regulatory, labour & employment, tax, products, competition, advertising, privacy, and trademark & patent registration. Innovation creates an ever-changing landscape. Our specialized life sciences team includes many individuals with advanced degrees, who bring an in-depth understanding of the technology on which your business is built to their legal advice. Whether you are early-stage or established, you need a legal team that can represent you on all legal and strategic matters.
Borealis Biosciences Inc.Vancouver, BChttps://www.borealisbio.com/RNA Medicines for Kidney Disease
BoxOne VenturesMontreal, QChttps://www.boxone.xyz/BoxOne Ventures is an early-stage investment firm. We invest our own capital in entrepreneurs we believe in. This gives us patience and flexibility from napkin to IPO.
BrevisRefero CorporationMilton, ONDrug, Therapeuticbrevisrefero.comt.c@brevisrefero.comDriving life-saving products to the clinic for patients that need them the most, BrevisRefero are biologics drug development CMC professionals with deep expertise in program outsourcing and delivery.
Bright Angel TherapeuticsToronto, ONhttps://www.brightangeltherapeutics.com/Bright Angel Therapeutics (BAT) is a pre-clinical stage biotechnology company focused on the development of novel therapeutics for the treatment of drug-resistant and life-threatening fungal infections. The company is powered by Schrödinger’s computational drug discovery platform in addition to proprietary technologies which the company has developed to enable design and development of fungal-selective inhibitors. BAT is currently working on two programs targeting invasive fungal infections (see pipeline). The company is headquartered in Toronto, Ontario, Canada.
Bright Minds BiosciencesVancouver, BChttps://brightmindsbio.com/Healing the central nervous system & brain through the regulation of serotonin
British Columbia - Trade and Invest BCVancouver, BChttps://www.britishcolumbia.ca/On the West Coast of Canada, British Columbia (B.C.) offers opportunity in expansion and capital investment across a wide range of industries, with trade representatives specializing in facilitating opportunities with investors from nations around the world.
Brock UniversitySt. Catharines, ONhttps://brocku.ca/linc/Brock University is a comprehensive institution recognized for world-class research that fuels the development of innovative products and services. At BIO 2025, we are seeking to connect with collaborators, industry partners, and investors to help accelerate the advancement and commercialization of novel technologies. Our high-potential assets include biotherapeutics, diagnostics, imaging, and synthetic chemistry.
CalianOttawa, ONServices: Contract Research, Development, Manufacturingcalian.compatricia.moore@calian.comCalian CRO offers full-service clinical trial solutions for Phase I-IV projects, as well as flexible Functional Service Provider staffing solutions. Calian PSP designs and implements customized PSPs that connect patients, healthcare professionals and pharmacies to deliver a high-quality patient and physician experience. Calian Digital Health solutions are designed to enhance access to high-quality healthcare by seamlessly connecting patients and care providers. Our solutions facilitate interoperability, secure communication and collaboration within care teams to improve patient outcomes.
Canada Pension Plan Investment BoardToronto, ONhttps://www.cppinvestments.com/The Canada Pension Plan Investment Board (CPPIB) is a professional investment management organization that manages the assets of the Canada Pension Plan (CPP) on behalf of 21 million Canadian contributors and beneficiaries. It was established in 1997 as an independent, arm’s-length entity from the federal and provincial governments. CPPIB ended its first quarter of fiscal 2025 on June 30, 2024, with net assets of $646.8 billion.  The Life Sciences investment strategy within Credit Investments at CPPIB provides flexible, highly customized capital solutions—such as pharmaceutical royalty monetization and structured financing—to support the growth of academic institutes and life sciences companies. 
Canadian Alliance for Skills and Training (CASTL)Charlottetown, PEcastlcanada.cainfo@castlcanada.caThe Canadian Alliance for Skills and Training in Life Sciences (CASTL) provides world-class technical skills development in life sciences specializing in biopharmaceutical manufacturing.
Canadian Institutes of Health Research (CIHR)Ottawa, ONhttps://cihr-irsc.gc.ca/e/193.htmlsupport-soutien@cihr-irsc.gc.caThe Canadian Institutes of Health Research (CIHR) is Canada's federal funding agency for health research. Composed of 13 Institutes, we collaborate with partners and researchers to support the discoveries and innovations that improve our health and strengthen our health care system.
Canary CureBurlington, ONBiotechnology, Diagnostics, Digital Health , Genomics, Lab Services, Medical Device, Medical Technology , Therapeutics www.canarydetect.com/ info@canarydetect.comCanary Global Inc. is a biotechnology company developing novel therapeutics and diagnostics for diseases caused by dysregulated microRNA expression. CGI is leveraging this Nobel Prize-winning discovery into an entirely new class of medicines. The company's lead product candidate is a small molecule drug that targets microRNA-21, a microRNA implicated in a wide range of diseases. Canary Global is also developing a point-of-care molecular diagnostic test that can be used to rapidly and accurately measure microRNA levels in blood or other bodily fluids.
Capital BioVenturesOttawa, ONNon-Profit, Industry Association, Incubatorcapitalbioventures.cajulia@capitalbioventures.caCapital BioVentures is an Ottawa Canada founded wet-lab accelerator program that removes hurdles for our Canadian innovators, while fostering a collaborative and cohesive ecosystem.Capital BioVentures was founded by a group of passionate entrepreneurs, biotech professionals and institutional experts local to the Ottawa ecosystem: Julia Pomoransky, Jeff Smirle, Maura Campbell, and David Stojdl. We have a singular focus: build more successful biotech companies that commercialize and scale in Canada. With this mission, we are offering seed-staged therapeutics and diagnostic companies:1. Early-stage funding in the form of cash2. Access to dedicated drug and corporate development biotech professionals3. Access to high quality, equipment fit up lab spacePlease reach out to learn more !
Cardiol Therapeutics Inc.Oakville, ONDrug, Therapeuticcardiolrx.comjohn.geddes@cardiolrx.comCardiol is a clinical-stage Phase 2 life sciences company focused on the research and clinical development of anti-inflammatory and anti-fibrotic therapies for the treatment of heart disease. Our purpose is to heal the heart with innovative science.
CaRe ClinicsCalgary, ABcareclinics.catroy@careclinics.caAt CaRe Clinics, we believe clinical research must never sacrifice quality, integrity, or compassion. For us, care stands for Clinical and Research Excellence, a promise we uphold in every trial we conduct. As Alberta’s leading community-based research network, our dedicated teams in Calgary and Red Deer balance scientific rigor with genuine empathy, understanding that behind every data point is a patient deserving respect and dignity. We deliver precise, high-quality research while creating environments where participants feel seen, heard, and valued.We intentionally foster inclusivity, striving to represent the diverse communities we serve. Our welcoming clinics build trust and meaningful relationships, empowering Sponsors, CROs, and investigators to achieve their goals and positively impact patients' lives.
Cassels Brock & Blackwell llpToronto, ONhttps://cassels.com/Cassels Brock & Blackwell LLP is a Canadian law firm focused on serving the transaction, advocacy, and advisory needs of the country’s most dynamic business sectors. Cassels offers one of the largest business law practices in Canada, advising clients from start-ups to multi-national organizations – across the street and around the world – and we are consistently cited as market leaders by such authorities as Chambers, Lexpert, and Best Lawyers. We are dedicated to staying on the leading edge of trends in law and business to offer practical and flexible solutions to your legal challenges, and our lawyers are proud to serve leadership roles in business, civic, charitable, and cultural organizations in community, national, and international organizations.
CatalisQuebecMontreal, QCSupport Orgs and Associationshttps://catalisquebec.comaobadia@catalisquebec.comCATALIS Quebec is an independent, non-profit organization, formally mandated and funded by the Government of Quebec to drive and coordinate provincial efforts in clinical research, ensuring that Quebec stands out internationally for the excellence and performance of its research environment. Acting as a neutral facilitator, CATALIS collaborates with a large network of public and private partners to accelerate the development of innovative treatments for patients while maximizing private investment in Quebec.
Catapulte communicationSaguenay, QChttps://catapultecommunication.com/en/Catapulte deploys communication strategies to position your organization in the public arena and with governments.
CATTIMontreal, QChttps://catti.ca/The Canadian Advanced Therapies Training Institute (CATTI) was created to efficiently and rapidly upskill the biomanufacturing workforce required in Canada and internationally. CATTI aims to: Bridge the gap between the academic background qualifications and the industry readiness of HQP (job-specific roles) Standardize the training curriculum for the needs of manufacturing sites to establish a quality standard for training, focused on best practices De-risk the process of training & developing HQP to the level of autonomy Reduce the training burden shared by all manufacturing sites by outsourcing it Diminish the funds allocated for training per employee by maximizing efficiency
CBREToronto, ONhttps://www.cbre.ca/With deep market knowledge, superior data and proprietary technology, our multi-dimensional perspective helps you use real estate to transform your business and find greater success.
CellCarta CanadaMontreal, QChttps://cellcarta.com/info@cellcarta.comAs a global Contract Research Organization Laboratory (CRO) to the biopharmaceutical industry, CellCarta provides access to a broad offering of biomarker platforms and services. We partner with you to address the most complex scientific testing needs, delivering customized biomarker testing solutions to further the limitless potential of precision medicine.CellCarta, which is under the private ownership of Arsenal Capital, is the union of scientific pioneers of the CRO industry supporting discovery, translational and clinical research.
Cell-Immune PharmaQCBiotech& Pharmahttps://immunitypharma.com/jf.cailhier@cell-immune.com, rejean@cell-immune.comCell-Immune Pharma is focusing on strengthening the next generation vaccines using the cellular immune response.
Celltrion, Inc.Toronto, ONhttps://celltrionhealthcare.ca/Celltrion Healthcare offers biologics to about 110 countries, along with more than 30 global partners around the world. With hands-on experience and knowledge accumulated through years of working in major worldwide markets, Celltrion Healthcare has secured distribution channels to provide patients with biosimilars at affordable prices. Celltrion Healthcare has now come to Canada to bring innovative biologic solutions to address Canadian healthcare needs.
Cencorahttps://www.cencora.com/A leading global pharmaceutical solutions organization committed to improving the lives of people and animals everywhere.
Centre d'expertise et de recherche appliquée en sMontreal, QChttps://cerasp.ca/fr/Le CERASP est un centre de transfert de technologie (CCTT) dans les sciences pharmaceutiques et les industries connexes. Nous sommes un centre de recherche appliquée spécialisé dans le soutien des PMEs dans leurs formulations de produits, prototypes, dépannage et affaires réglementaires (partenaire Santé Canada), ainsi que dans l’élaboration de processus et de protocoles de production. Nous vous soutenons dans la préparation aux audits ainsi que vérifications effectuées par Santé Canada et la FDA.
Centre for Addiction & Mental HealthToronto, ONcamh.ca/en/science-and-researchklara.vichnevetski@camh.caThe Centre for Addiction and Mental Health (CAMH) is Canada's largest mental health and addiction teaching hospital, as well as one of the world's leading research centres in the area of addiction and mental health.
Centre for Commercialization of Regenerative MedicineToronto, ONhttps://www.ccrm.ca/CCRM is a catalyst for commercializing regenerative medicine-based technologies and cell and gene therapies. We enable product development through the unique translational platforms that address the key bottlenecks in regenerative medicine commercialization.
CERASP (Centre d'expertise et de recherche applique en sciences pharmaceutiques - Center of expertise for applied research in the pharmaceutical sciences)Montreal, QCDrug, Therapeutic,Diagnotics, Device,Digital Health Service:Contract Research,Development, Manufacting, Services:Legal,Consulting,Business Investor,Non-profit, Industry Association, Incubator,Academichttps://cerasp.ca/bobby.boursiquot@cerasp.caThe CERASP is a non-profit organization whose mission is to provide applied research and technical support leading to technology transfer for the development of innovative solutions in the life science industry. We provide turnkey flexible solutions to help businesses in their product development path. From early-stage discovery to scale-up and technical transfer for GMP-ready production, we facilitate the commercialization journey by blending innovation with expertise.
CereCura Nanotherapeutics Inc.Vancouver, BChttps://www.cerecura.com/We are dedicated neuroscientists and drug delivery experts. We are focused on addressing major therapeutic challenges in the brain and bringing hope to patients with neurological disorders through innovative RNA therapies.
Charles River Laboratories InternationalLaval, QChttps://www.criver.quebec/Accompagner nos clients pour accélérer le développement de nouvelles thérapies, produits chimiques et dispositifs médicaux pour les personnes et les patients qui en ont besoin.
Chronic Disease Innovation CentreWinnipeg, MBServices: Contract Research, Development, Manufacturinghttps://changinghealthcaredelivery.ca/contact/ mdinella@sogh.mb.ca, rwhitlock@sogh.mb.caAs an independent non-profit corporation, CDIC provides a hub for clinicians and researchers to work together with business and industry partners, positively impacting everything from patient care to improving business operations. CDICalso serves as the research arm for Seven Oaks General Hospital and the hospitals Wellness Institute.CDIC has built a sustainable research infrastructure with robust team of five nephrology researchers, one nutrition researcher, over 25 research staff, and numerous trainees of all levels. Our teams multidisciplinary skills are a unique advantage, with staff members trained in areas such as psychology, business, nutrition, statistics, and project management, along with clinical and medical expertise.
CHU de QuebecLaval, QChttps://www.chudequebec.ca/accueil.aspxnspiré par les gens qui animent son quotidien, le CHU de Québec–Université Laval (CHU) vise l’excellence et offre des soins et des services empreints d’humanisme à la population. Engagées et innovantes, ses équipes concentrent leurs efforts au bénéfice de la personne. Elles façonnent les soins d’aujourd’hui et de demain, forment la relève, contribuent à une recherche d’avant-garde et évaluent les technologies et les pratiques en santé. Doté d’une vision et d’un savoir reconnus, le CHU contribue à de nombreux projets dans les domaines de la santé, de la science, du partage du savoir, du développement économique et social.
CHU Sainte-JustineMontreal, QChttps://research.chusj.org/en/HomeResearch at CHU Sainte-Justine: overview Ensuring the health of children and mothers-to-be Driven by a passion for excellence, we are committed to making Quebec into a place where the health of mothers-to-be, children and youth ranks among the best in the world. With this in mind, we are intent on advancing knowledge and applying new research findings in order to translate new discoveries into more efficient and less invasive methods and devices aimed at disease prevention, diagnosis, prognosis, treatment and long-term follow-up starting at conception and continuing throughout the journey to adulthood. In recent years, various sources of government and philanthropic funding have paved the way for new leading-edge infrastructure and the development of large-scale national and international networks, cementing our leadership with regard to innovative, multidisciplinary research in mother-and-child health in Quebec.
City of BramptonBrampton, ONNon-Profit, Industry Association, IncubatorinvestBrampton.camartin.bohl@brampton.caProvide access to government services, connections to hospitals, and local incubators for health and related services including cybersecurity.
City of HamiltonHumilton, ONhttps://www.hamilton.ca/To protect and rehabilitate Hamilton’s unique biodiversity assets, a coordinated approach between the City of Hamilton and local community environmental partners has been adopted by the City of Hamilton. The Biodiversity Action Plan (BAP) will assist in ensuring that the City and the local conservation community partner organizations work together to enact change. Through these collaborations, actions will be taken for protecting, enhancing, and restoring biodiversity in Hamilton.
Clinical Trials OntarioToronto, ONNon-Profit, Industry Association, Incubatorctontario.caelena.trebinjac@ctontario.caEstablished in 2012 with support from the Government of Ontario, Clinical Trials Ontario (CTO) is a leading non-profit organization in the clinical trials community dedicated to strengthening, promoting and capitalizing on Ontario’s competitive advantages for conducting high-quality clinical trials. We foster partnerships and work collaboratively with the clinical trials community to improve the clinical trials environment, cut through red tape and attract investment to the province, while supporting the highest ethical and quality standards.
Congruence TherapeuticsMontreal, QCDrug, Therapeuticcongruencetx.comCongruence Therapeutics is building a pre-eminent next-generation drug discovery company by harnessing a distinctive, scalable computational platform, Revenir™, to rapidly and efficiently discover a pipeline of small molecules to correct severe disease
Contract Pharmaceuticals Limited (CPL)Mississauga, ONhttps://cplltd.com/At CPL, we provide end-to-end solutions for our clients, including in-house product development, manufacturing, packaging, and testing. Our in-house solutions eliminate the need for technology transfer, reducing risks and costs for our clients.
COREALIS Pharma IncLaval, QCPartners for your drug discovert, pre-clinical and clinical phasewww.corealispharma.comdavid.kwajewski@corealispharma.comContract formulation development and phase I/II/III clinical supplies manufacturing and packaging of pharmaceutical oral solid dosage forms.
CoSality Executive PartnersToronto, ONhttps://cosality.ca/CoSality delivers Amplified Executive Intelligence™—A(E)I—to industry leaders through the powerful integration of veteran fractional executives with cutting-edge AI tools designed for biotech.   Our solutions include: Commercial Planning: clinical-to-commercial transition, GTM strategy, inline brand management, LCM, market and customer analytics, and more Operational Execution Excellence: launch execution, process optimization, team development, business scaling, quality excellence, implementation management, and more Investment Planning: investor-ready pitch development and delivery, pitch simulations, pitch assessments and investment memo creation for investors Staff Augmentation: veteran executives at a fractional of the cost of a permanent FTE  With fractional Chiefs of Staff, CFOs, CCOs, COOs, and other executives, we are “The Suite Spot”, delivering strategic clarity, operational excellence, and accelerated business results.   There is nothing artificial about our intelligence!  
CPDCHumilton, ONcpdc.cacatherine@cpdc.caThe Centre for Probe Development and Commercialization (CPDC) specializes in nuclear medicine. We are seeking radiopharma in-licensing and direct investment opportunities in therapeutics, diagnostics and related technologies.
CPDNMississauga, ONhttps://www.cpdn.ca/For over 25 years, CPDN has been a leading distribution channel to Canadian hospitals. Our members leverage our consolidated distribution model and comprehensive technology services to operate with greater efficiency and transparency, leading to reduced operational costs and back-office time.
CQDMMontreal, QCSupport Orgs and Associationswww.cqdm.orgxlinker@cqdm.orgCQDM is a non-profit biopharmaceutical research consortium whose mission is to support and facilitate multi-stakeholder collaborative R&D that accelerates translation of leading-edge discoveries into vaccines, therapeutics and diagnostics addressing unmet medical needs while generating significant benefits for the Canadian economy.
Creative Destruction LabToronto, ONhttps://creativedestructionlab.com/Creative Destruction Lab (CDL) is a nonprofit organization that delivers an objectives-based program for massively scalable, seed-stage, science- and technology-based companies.
CTI Life SciencesMontreal, QCInvestorctisciences.comxhang@ctisciences.comCTI Life Sciences Fund (CTI) is a leading Canadian life sciences venture capital (VC) firm that invests where the needs of pharma and patients intersect. Our core investment focus is biotherapeutic companies in the pre-clinical to early-clinical stage.
Cumming School of Medicine (U of C)Calgary, ABAcademiccumming.ucalgary.caelsa.reisenhofer@ucalgary.ca
Custom BiologicsEtobicoke, ONDrug, Therapeuticcustombiologics.comdmamelak@custombiologics.comCustom Biologics provides regulatory compliant potency testing and assay services for all phases of biotherapeutic drug development and manufacturing. Their biologics division designs and validates highly specialized ligand-binding and cell-based potency bioassays to support the functional characterization, activity assessment, pharmacokinetics, immunogenicity and clinical testing requirements of biologic, oncolytic virus, vaccine, and gene therapy drug candidates. Their genomics division develops sensitive and rapid nucleic acid tests. Custom Biologics maintains a Health Canada cGMP Drug Establishment License.
Dalhousie UniversityHalifax, NSdal.caDalhousie University combines high-impact research, meaningful teaching, and a deep sense of social responsibility that inspires our diverse community to make a difference here in Nova Scotia, across Canada, and on the global stage.
Dalriada Drug DiscoveryMississauga, ONDrug, Therapeuticdalriadatx.comdiana@dalriadatx.comDalriada is a leading North American discovery company pioneering its novel Turn-Key™ model in small molecule drug discovery. Purpose-built and partner-centric, they integrate expertise across chemistry, biology, protein sciences, chemoproteomics, and discovery strategy to accelerate even the most challenging programs. Dalriada’s innovative iCLASS platform combines multi-proteomics data generation with machine learning, unlocking biologically relevant, translatable insights into target druggability. iCLASS redefines what's possible—delivering hits and programs for the most “undruggable” targets.
Dalton Pharma ServicesToronto, ONhttps://www.dalton.com/Dalton is a leading contract service provider of integrated drug development & manufacturing services to the pharma & biotech industries. We can accelerate your drug development process by integrating process development, API & finish dose manufacturing.
DCx BiotherapeuticsVancouver, BChttps://dcxbio.com/DCx Biotherapeutics is a preclinical-stage discovery and translational company addressing key dependencies of cancer lesions by developing multi-modal synergistic-targeting therapeutics with improved efficacy and tolerability while minimizing resistance. DCx’s MuSic™ platform is enabled through the integration of CRISPR-based high-throughput functional screening combined with deep bioinformatics in support of advancing a pipeline of immune-stimulatory precision antibody drug conjugates to improve therapeutic outcomes against genetically-defined cancers.
Deep GenomicsToronto, ONdeepgenomics.comDeep Genomics is an AI-first TechBio organization pioneering a new path for genomic R&D through its multidisciplinary team of AI and biology scientists and its Foundation Model Platform. Leveraging cutting-edge AI technologies and biological insights, Deep Genomics is at the forefront of revolutionizing drug discovery and development. Through its innovative approach and collaborative partnerships, Deep Genomics aims to accelerate the delivery of life-saving therapeutics to patients worldwide. Deep Genomics is located in Toronto, Ontario, and Cambridge, Massachusetts. For more information, visit www.deepgenomics.com and follow us on LinkedIn. 
Defence Therapeutics Inc.Vancouver, BChttps://defencetherapeutics.com/Accum™ Technology’s proprietary and patented drug delivery platform has 10x the impact on infected cells over other approved solutions.
DELPHARMBoucherville, QChttps://www.delpharm.com/Delpharm is a European CDMO developing and manufacturing drug products. We offer: •early formulation • process development • analytical methods • stability studies • clinical batches / placebo • commercial manufacturing • regulatory affairs
Desire VenturesMontreal, QChttps://desireventures.com/Our model is to identify novel therapeutics with high potential for entering first in human clinical trials along with having strong scientific proof of concept and identifying the most promising path forward for regulatory approval and clinical Phase 2 ready status. Our funding is derived from a combination of global grants and a network of private investors, to enable us to form targeted collaborations and new ventures, lift their talent towards a greater purpose, and maximize their probability of success, without sacrificing speed or flexibility. We have pioneered a resourceful model that facilitates an optimized project management process, a regulatory compliant management system and an assortment of strategies towards de-risking scientific innovation, achieving significant reduction of burn rates and time efficiencies. Our growth advisors, funding managers, sector experts and serial entrepreneurs that have a proven track record in successfully leading companies on their growth paths, are here to help you optimize for your deliverables and develop benchmarks to help you scale. With a diverse group of skillsets and backgrounds, each member of our team brings a unique perspective and set of strategies to maximize our strategic investments.
DHW
DiaMentisQuebec City, QCPartners for your drug discovert, pre-clinical and clinical phasehttps://diamentis.com/en/bguimont@diamentis.comdiaMentis is a late-stage biotechnology company Granted FDA Breakthrough Designation and revolutionizing mental health diagnostics with retinal signal analysis. Highlighted in the peer-reviewed international journal Biomedical Signal Processing and Control, diaMentis unveils unprecedented results. Our AI-platform Software-as-Medical-Device (SaMD) technology enables faster, objective, and precise detection of psychiatric and non-psychiatric disorders, addressing a critical unmet need in mental healthcare and unlocking new revenue opportunities for healthcare providers and partners.
Diex Recherche IncSherbrooke, Quebec City, Victoriaville, QCPartners for your drug discovert, pre-clinical and clinical phasediex.castalbot@diex.caDedicated exclusively to clinical research, Diex Recherche conducts phase II to IV trials to pharmaceutical and biotechnology companies. 
District 3Montreal, QCSupport Orgs and Associationsdistrict3.coanmol.nagpal@district3.coOur holistic approach combines tailored coaching, sector-specific expertise, ESG-focused strategies, and access to state-of-the-art labs, collaborative workspaces, and global networks.
Domain TherapeuticsMontreal, QChttps://www.domaintherapeutics.com/Delivering breakthrough GPCR-targeting therapies that bring hope to patients, especially in immuno-oncology and inflammation. We harness the transformative power of GPCR science to address significant unmet medical needs. By translating intricate GPCR biology into highly differentiated therapies, we challenge traditional approaches and deliver innovative strategies with the potential to change lives.
DUet Therapeuticshttps://duettx.com/Duet BioTherapeutics is an immuno-oncology company creating a new category of bifunctional and cell-selective oligonucleotide treatments designed to target dormant immune cells within the tumor microenvironment. Targeted activation of these antigen-presenting cells removes the immunosuppressive shield around the tumor and jump-starts T cell-mediated immune responses to kill cancer cells.
Duoject Medical Systems Inc.Bromont, QChttps://duoject.com/Duoject Medical Systems is a design and development firm specializing in advanced medical devices, particularly in the areas of drug reconstitution, injectable administration, and safety systems. Founded in 1985 and located in Bromont, Québec, the company operates as a wholly owned subsidiary of Novocol Pharma, which is part of the Septodont group.?
DynacareToronto, Scarborough, ONPre clinicalwww.dynacare.cacicirettov@dynacare.caAt Dynacare, our services are as extensive as our history is deep. Our roots lie in providing essential medical testing that empowers patients and their physicians to better diagnose, understand and manage medical conditions. With a team of dedicated scientific and technical staff we are at the forefront of laboratory medicine – and can provide advanced diagnostics to meet your unique needs in a cost effective, timely and precise fashion.
Eder TherapeuticsSaguenay, QChttps://www.edertx.ca/Eder Therapeutics is rare disease biopharmaceutical company headquartered in Canada. We are focused on the development and commercialization of AAV Gene Therapies and novel targets identified through whole exome sequencing (WES). We are focused on bringing innovations to Canadians and identifying partners for global development.
Edesa Biotech Inc.Markham, ONDrug, Therapeuticedesabiotech.cominvestors@edesabiotech.comWe are a biopharmaceutical company focused on acquiring, developing and commercializing clinical-stage drugs for inflammatory and immune-related diseases with clear unmet medical needs.
Edmonton GlobalEdmonton, ABedmontonglobal.carsikora@edmontonglobal.caEdmonton Global is a foreign direct investment (FDI) and international business development agency, located in the Western Province of Alberta in Canada where we represent the Edmonton Region. The Edmonton region is accelerating research and development and increasing productivity in life sciences and has strengths in pharmaceutical manufacturing, drug discovery, nutraceuticals, diagnostics, medical devices, and sits at the convergence of artificial intelligence and health.; Companies in the region benefit from operating in Alberta which is home to Canada's largest, fully integrated healthcare system that serves a diverse population of 4.3 million people.; ; Collaboration, digitalization, strong academic and industry partnerships paired with an entrepreneurial mindset have led to a boom in this sector. The region is teeming with potential strategic partners for anyone looking to invest.; ; Health and life science companies in the Edmonton region are part of a strong, growing, and tight-knit community working at the cutting edge of scientific breakthroughs. Scientists are at the forefront of research in diabetes, virology, and precision health, and we have world class facilities to prove it.; ; Anchored by world class institutes such as the University of Alberta and the Alberta Machine Intelligence Institute whom are ranked top 3 Globally for their innovation and excellence in Artificial Intelligence.
EKS VenturesToronto, ONhttps://eksbizdev.com/EKS Ventures is a venture studio that builds early-stage life science companies. We partner with scientists and entrepreneurs to turn promising therapeutic and medtech innovations into fundable, growth-ready ventures. We support companies through key commercialization activities, including technology-market fit, business strategy, strategic partnering, and fundraising strategy. Our goal is to actively launch and grow innovative life science companies on the path to commercial success.At BIO, we are representing the following promising start-up companies: Neuropeutics, NuvoBio, Inteligex Inc., Metares TherapeuticsWe also have a particular interest in ageing and muscle regeneration.
EncephalXQCPartners for your drug discovert, pre-clinical and clinical phaseEncephalx | Recherche et développement en produits crâniensmathieu.laplante@criucpq.ulaval.caEncephalX is committed to redefining the standard of care for patients with traumatic brain injuries or strokes. Conventionally treated in two surgeries, our Dynamic Cranioplasty System (DCPS) offers a safer, more efficient solution that enhances patient outcomes and reduces recovery time with a streamlined, single-procedure approach. 
Entos PharmaceuticalsEdmonton, ABentospharma.comjason.ding@entospharma.comEntos Pharmaceuticals' Fusogenix™ Proteo-Lipid Vehicle™ (PLV™) platform, enables precision non-viral, re-dosable delivery of all nucleic acids payloads (DNA, RNA, or combinations), ushering in the new era of genetic medicine.
Environmental Systems CorporationBarrie, ONhttps://www.e-s-c.com/Cleanroom & BSL Solutions Our Mission is to enhance the knowledge and skills of the project team for the successful delivery of specialty environments with our systems expertise. Using an Integrated Project Delivery on your Cleanroom Project: Will save you initial and ongoing costs, Understand the options and the rationale behind the choices, Allow you to meet your budget, Informed choices means a better project.
EpitopeaMontreal, QCDrug, Therapeuticepitopea.cominfo@epitopea.comEpitopea is a global leader in exploiting a novel class of shared, non-mutated tumour-specific antigens (TSAs) designed to treat broad cancer patient populations.
Eupraxia Pharmaceuticals Inc.Victoria, BCDrug, Therapeuticeupraxiapharma.comEupraxia develops new applications for existing products using its highly differentiated delivery technology. Its lead products are EP-104IAR which is entering Phase 3 for knee OA, and EP-104GI which is in Phase 1b/2a for EoE and GI strictures.
Eurofins CDMO Alphora Inc.Mississauga, ONServices: Contract Research, Development, Manufacturingeurofins.comCDMOAlphora@bpt.eurofinsca.comEurofins CDMO Alphora Inc. is a full service contract research organization, with a specialization in API and Drug Product development and manufacturing services for complex small molecules and biologics, including highly potent compounds and ADCs.
EVERSANA CanadaToronto, ONServices: Legal, Consulting, Businesseversana.comzahir.ratanshi@eversana.comEVERSANA is a global services provider to the life science industry with integrated solutions rooted in the patient experience. EVERSANA's capabilities span all stages of the product lifecycle to deliver long-term, sustainable value for patients, prescribers, channel partners and payers. The company serves hundreds of organizations, from start-ups to big pharma, to advance life science services for a healthier world.
Evolved TherapeuticsRichmond, BChttps://www.evolvetherapeutic.com/ Evolve Therapeutic is dedicated to providing the highest standard of Massage Therapy, Physiotherapy, Acupuncture, Chiropractic, Kinesiology, and Clinical Counselling care to our patients. Each of our fourteen therapists has graduated from an accredited college in B.C. and are members in good standing in their respective associations.
Evonik Health CareBurnaby, BCBiotechnology, Contract Research & Scientific Services, Scientific Supplieshttps://healthcare.evonik.com/enhealthcare@evonik.comEvonik is one of the world leaders in specialty chemicals. The company is active in more than 100 countries around the world and generated sales of 15 billion and an operating profit (adjusted EBITDA) of 2.38 billion in 2021. Evonik goes far beyond chemistry to create innovative, profitable and sustainable solutions for customers. More than 33,000 employees work together for a common purpose: We want to improve life, today and tomorrow.
Eyam HealthSurrey, BCeyamhealth.comcontact@eyamhealth.comEYAM is a platform company with strong animal efficacy data for a self-amplifying AI-informed RNA/DNA smart vector. We are seeking investment and strategic partnership opportunities.
Eyesciences
Famililab Canada Inc. Boisbriand, QChttps://www.famililab.care/business@famililab.careThe Famililab.Care Medical Ecosystem provides real-time personalized medical plan services for patients and high-risk populations through the interconnectivity of medical data and real-time monitoring and dynamic adjustment of healthcare data. We adhere to the concept of value-based care, using medical data as the core to improve patient health outcomes, reduce healthcare costs, enhance quality of life (QOL), and achieve value-based care (VBC)."
Feldan TherapeuticsQC, QCBiotech& Pharmahttps://www.feldan.comvmenard@feldan.comFeldan Therapeutics is a clinical biotechnology company developing leading-edge treatments based on its proprietary peptide-based intracellular delivery technology, the Feldan Shuttle platform. The Shuttle’s ability to bind to cell membranes and to disrupt nascent endosomes enables the delivery of small molecules, proteins, nuclease complexes, peptides and antisense oligonucleotides (ASOs) inside cells. Feldan’s lead program, is an intralesional drug composed of a Shuttle and an ASO targeting Gli1, the master regulator of the Hh pathway.
Fibrocor TherapeuticsToronto, ONhttps://www.fibrocortherapeutics.com/Fibrocor has exclusive access to a clinical annotated biobank of over 5000 biopsies from patients with liver, lung and kidney fibrotic diseases. Fibrocor discovered 3 novel druggable targets that block the Fibrosis Stiffness pathway and designed high q
FibroDynamxCalgary, ABhttps://www.fibrodynamx.com/FibroDynamx is a drug discovery company with a proprietary platform for drug target identification based on regenerative healing models. There are no existing treatments on the market that prevent scarring, however medical need and pharmaceutical demand is considerable. Our first product (FD-001) is a protein-based drug that improves scarring and skin regeneration by 10-fold in pre-clinical models. We are raising $1.3M CAD to support IND-enabling studies.
Fonds de recherche du Quebec SanteMontreal, QCfrq.gouv.qc.ca/santepaul.larcheveque@capcogito.comDisease prevention. Better care. Our scientists are looking for solutions so that we can live healthier lives. At the Fonds de recherche du Quebec – Sante (FRQS), we offer them financial support while ensuring the strategic and coherent development of health science research in Quebec.
FreshLeaf MarketingGuelph, ONServices: Legal, Consulting, Businessfreshleafmarketing.cajennifer@freshleafmarketing.caAt FreshLeaf Marketing, we help multi-6 and 7-figure B2B life science businesses stand out, get found, and gain more leads through a strategic, integrated marketing approach. Learn more at www.freshleafmarketing.ca
FTQQC, Brossard, Anjou, Montreal, QChttps://www.fondsftq.com/mpesant@fondsftq.comThe Fonds de solidarité FTQ is a source of pride in Québec, fulfilling its mission through a business model created more than 40 years ago. Since then, the Fonds has rallied Québec into action thanks to the retirement savings of 795,374 shareholders.
Future Fields Cellular AgricultureEdmonton, ABfuturefields.iochris@futurefields.ioDifficult protein expression that scales by harnessing the multicellular expression prowess of Drosophila melanogaster. We help biotech/biopharma conserve budget and make great proteins, unlocking new products and workflows.
Galenvs SciencesMontreal, QCPre clinicalwww.galenvs.comxhoa@galenvs.comGalenvs is a specialized precision developer & manufacturer of nanomaterials and DNA/RNA oligonucleotides for therapeutics and diagnostic applications, offering services from proof-of-concept through in-vitro validation and pilot-scale production.
GenaizMontreal, QChttps://genaiz.com/catherine.lunardi@genaiz.comGENAIZ offers a powerful data orchestration platform purpose-built for the life sciences industry. We empower pharmaceutical sponsors, manufacturers, CROs, hospitals, and academic labs to make their data “talk” fast using advanced, AI-powered Smart Functions.?Our Intelligent Automated solutions break down silos across Regulatory, Quality, Laboratory, and R&D functions—streamlining processes, enhancing compliance, and accelerating decision-making.
Genesys Capital Partners Inc.
Genome QuebecMontreal, QChttps://genomequebec.com/en/jrlandry@genomequebec.comGénome Québec, a non-profit organization, was established in 2000. Since its inception, it has helped Québec make great strides in genomics research. Over the years, projects funded by Génome Québec and its Innovation Centre have made significant contributions to many areas of activity. That is why genomics is now considered to be the great white hope of economic development, particularly in health, agrifood, forestry and the environment.
GL CHEMTEC INTERNATIONAL LTD.Oakville, ONServices: Contract Research, Development, Manufacturingglchemtec.caFor over two decades, GL CHEMTEC has been dedicated to delivering innovative solutions with unrivalled speed, agility, and passion. We are committed to accelerating the development of new drugs, intermediates, materials, and devices that significantly enhance the human condition. We understand the urgency of our customers' needs and the responsibility we bear in serving researchers who rely on our solutions. By combining cutting-edge technology with robust scientific principles, we empower our customers' success and strive to exceed their expectations.
GlaxoSmithKline CanadaMississauga, ONhttps://ca.gsk.com/en-ca/We are a focused biopharma company. We prevent and treat disease with specialty medicines, vaccines, and general medicines. We focus on the science of the immune system and advanced technologies, investing in four core therapeutic areas - respiratory, immunology and inflammation; oncology; HIV and infectious diseases – to impact health at scale. Our Ahead Together strategy means intervening early to prevent and change the course of disease, helping to protect people and support healthcare systems.
Global Affairs Canada Trade Commissioner Service
Global Health Visionshttps://www.globalhealthvisions.com/Global Health Visions strives to improve the health and well-being of individuals and communities in the U.S. and around the world. We provide exceptional guidance, innovative analysis, and targeted solutions to organizations working in the health and development sectors. We are committed to empowering our partners to maximize the impact of their efforts by providing access to expert consultants that are creative, passionate, and deeply knowledgeable about the issues.
GLOBAL PUBLIC AFFAIRSOttawa, Toronto, ONhttps://globalpublicaffairs.ca/We are Canada’s largest privately-owned, fully integrated public affairs firm. With over 85 expert consultants, we work with an ever-expanding list of Canadian and international clients in multiple aspects of their business, providing strategic counsel and services to various for-profit and not-for-profit organizations.
GlycoNetEdmonton, ABcanadianglycomics.caenanak@ualberta.caGlycoNet is a national research network leveraging glycomics to develop innovative technologies, diagnostics, treatments, and vaccines for multiple diseases.
Government of CanadaOttawa, ONhttps://www.international.gc.ca/country-pays/us-eu/washington.aspx?lang=engCanada's Trade Commissioner Service facilitates trade and innovation partnerships between Canadian life sciences companies and their counterparts around the world.
Government of Manitoba, CanadaWinnipeg, MBGovernmenthttps://www.manitoba.ca/index.htmlminbmtjc@manitoba.ca,robert.balon@gov.mb.ca,dmbmtjc@manitoba.caThe Government of Manitoba - Business, Mining, Trade & Job creation is dedicated to fostering economic growth, job creation and sustainable resource development across the province. The department focuses on attracting private investment, supporting business expansion and promoting trade opportunities, while also ensuring the responsible management of manitoba's resources. Trough initiatives like the Premier's business and job council, it collaborates with industries, indigenous communities and other stakeholders to build low-carbon economy. they offer a range of programs and incentives to support entrepreneurs, exporters and regional development efforts.
Government of Newfoundland & LabradorSt. John, NLhttps://www.gov.nl.ca/info@gov.nl.cathe Government of Newfoundland and Labrador seeks to improve service to the public by increasing awareness of provincial government programs and services, business opportunities, and tourism potential.
Government of Nova ScotiaHalifax, NShttps://beta.novascotia.ca/The Province is helping biotechnology incubator the Verschuren Centre increase capacity at its Cape Breton fermentation plant to support more clients, advance automation and create more skilled jobs. The funding will position Nova Scotia for more national and international investment in this important sector. “This is another great achievement for Cape Breton and for the team at the Verschuren Centre.
Government of Ontario, CanadaToronto, ONhttps://www.ontario.ca/page/government-ontario
Government of Ontario, Ministry of Economic Development, Job Creation and TradeToronto, ONGovernmentsourcefromontario.comcharley.ford@international.gc.caOntario, Canada is driving the next wave of life sciences innovation. Developing the health technologies of tomorrow, Ontario is leading in health research and nuclear medicine. Home to world-renowned research centres, academic hospitals and companies, and powered by a collaborative spirit and deep talent pool, Ontario's life sciences sector offers unparalleled opportunities for companies changing the face of healthcare.
Government of PEICharlottetown, PEIhttps://www.princeedwardisland.ca/enThere is considerable focus and energy being directed to the PEI bioscience sector from within industry, government, and academia. Entrepreneurs from across the globe are realizing that Prince Edward Island is a land of opportunity and there is significant commitment and drive aiding commercial success. From multi-national corporations to small and medium enterprises, contract research organizations and contract manufacturing organizations, the foundations for a strong bio-platform and the desire to make it work can be found on Prince Edward Island.
GOWLING WLGOttawa, ONhttps://gowlingwlg.com/en-caGowling WLG is an international law firm built on the belief that the best way to serve you is to be in tune with your world, aligned with your opportunity and ambitious for your success.
Groupe Magellan | St-AmourMontreal, QChttps://expert.st-amour.com/Nous parlons pharmaceutique et médical, industriel, ingénierie, construction, biens de consommation, services aux entreprises et bien plus. Et nous adorons ça! C’est pourquoi nous mettons tout en œuvre pour vous offrir un partenariat fructueux : experts en recrutement attitré, analyse minutieuse de vos besoins, équipe expérimentée, suivi personnalisé, écoute, transparence et intégrité. Notre équipe expérimentée est là pour satisfaire tous vos enjeux d’affaires.
Groupe PARIMAMontreal, QCPartners for your drug discovert, pre-clinical and clinical phasewww.groupeparima.comldcantin@groupeparima.comGroupe PARIMA is a CDMO specializing in the development and manufacturing of non-sterile pharmaceutical products, offering full services from product development to commercial manufacturing and packaging.
GSK PharmaceuticalsMontreal, QChttps://ca.gsk.com/fr-ca/We manufacture innovative vaccines and specialty medicines to prevent and treat diseases. Our R&D focuses on the science of the immune system, human genetics, and cutting-edge technologies.
Haplo Therapeuticshttps://haplo-ips.eu/
HDAX TherapeuticsToronto, ONDrug, Therapeutichdaxtx.comnabanita@hdaxtx.comHDAX Therapeutics, a biotechnology company pioneering a novel approach to target HDAC6 to address critical unmet medical needs in cardiometabolic/renal and select neurological diseases. Their innovative 2-site binding mechanism has the potential to deliver best-in-class HDAC6-targeting therapeutics and tackles major limitations of first generation compounds. HDAX closed an oversubscribed $4M seed financing round in Q4 2024 to nominate a development candidate and advance its pipeline programs.
Health Care FoundationSt. John, NLhttps://healthcarefoundation.ca/Medical equipment and procedures are constantly evolving and advancing. By supporting the Health Care Foundation, you ensure your doctors and nurses have the latest tools, technology, and training they need to do a better job of getting you better. The Health Care Foundation supports nine adult hospitals and health centres under the purview of Eastern Health. Our hospitals provide tertiary care for all of Newfoundland and Labrador, and residents of St. Pierre and Miquelon.
HexirisDieppe, NBhttps://hexiris.ca/Hexiris is a medtech company committed to advancing ophthalmic devices that simplify treatments and improve access for patients in need. Our goal is to empower ophthalmologists with tools that are not only effective but also practical in diverse clinical settings. Currently, Hexiris is developing several groundbreaking devices. One example is our Advanced Technology Device designed for office-based Minimally Invasive Glaucoma Surgeries (MIGS). This first-of-its-kind innovation has been tested and holds the promise of transforming glaucoma care by making it simpler and more accessible for both patients and practitioners.
Holman ExhibitsMarkham, ONhttps://www.holmanins.ca/Holman Insurance Brokers is dedicated to supplying you with customized insurance products and services. Since our inception in 1981, Holman has focused on providing insurance protection for specialized professions and complex risks. That’s why we understand the diverse and evolving needs of each of our clients. That’s also why we have been able to anticipate and respond to your changing requirements with the strategic acquisition of leading-edge brokerages with extensive knowledge of a wide variety of unique industries and products.
Hologic Canada ULCMississauga, ONBiotech& Pharmawww.hologic.caisabelle.fortier@hologic.comHologic is an innovative medical technology company whose primary goal is to improve the health and well-being of women through early detection and treatment.
HTuO BiosciencesVancouver, BChtuobio.cominfo@htuobio.comHTuO Biosciences is a computational biotechnology company. Utilizing a novel molecular physics model we aim to accelerate drug optimization and discovery.
Hub InternationalOttawa, ONhttps://www.hubinternational.com/en-CA/Risk & Insurance | Employee Benefits | Retirement & Private Wealth
Icosa PharmaMoncton, NBhttps://convention.bio.org/exhibitors/icosa-pharmaIcosa Pharma Inc. was founded in late 2024 as a start-up company that spun out of the University of Moncton in Canada. We have developed a family of proprietary (patents in North America and Europe) novel anti-inflammatory small molecules that are in the pre-clinical stage of development. Our goal is to develop these molecules for the following indications:1. Alzheimer’s disease and related tau pathologies. A first line oral therapy that could be used to slow or reverse disease progression.2. Rheumatoid arthritis. In RA, a first-line oral therapy that could be used alone or adjunctive and complementary to first-line RA drugs.
Idorsia PharmaceuticalsMontreal, QCBiotech& Pharmaidorsia.comWe have a diversified and balanced portfolio covering multiple therapeutic areas, including central nervous system (CNS), cardiovascular, and immunological disorders, as well as orphan diseases. We have received regulatory approval and are commercializing QUVIVIQ (daridorexant) indicated for the management of adult patients with insomnia, characterized by difficulties with sleep onset and/or sleep maintenance.
Illumina, IncToronto,Vancouver, ON,BChttps://www.illumina.com/Illumina is committed to building our company with integrity and ethical business behavior. Since 2008, Illumina has convened an Ethics Advisory Board (EAB) to support its commitment to ethical and just business operations. The EAB meets quarterly to advise and provide recommendations regarding ethical issues involving existing, emerging, and prospective products, services, and processes both from a research and clinical perspective. This includes providing strategic advice to Illumina regarding emerging ethical issues, policies, and regulations relevant to the genomics industry.
Immugenia Inc.Sherbrooke, QCDrug, Therapeuticimmugenia.comImmugenia Inc. is an immuno-oncology company developing a novel approach to CAR therapy by engineering hematopoietic stem cells using specific synthetic promoters leveraging both T and NK cells to treat cancer and prevent relapses, potentially for life
Immune Biosolutions incSherbrooke, QCDrug, Therapeuticimmunebiosolutions.cominfo@ibiosolutions.comImmune Biosolutions is a company that utilizes the unique properties of the avian immune system to generate novel antibodies for the development of immuno-therapies, notably in cancer.
ImmunoBiochem CorporationToronto, ONDrug, Therapeuticimmunobiochem.comceo@immunobiochem.comImmunoBiochem is an innovative biopharmaceutical company developing novel bioconjugate therapeutics, such ADCs and DACs, to address significant unmet need in oncology and immunology. ImmunoBiochem’s novel bioconjugates for precision immunology utilize unique antibody targets for the delivery of potent protein degrader payloads modulating select immunological pathways in specific cell subtypes in the desirable context in relevant autoimmune disorders. This precision strategy increases efficacy allowing the full potential of modulating important immunological pathways to be realized, while avoiding the broad side-effects that limit existing biologics and small molecule therapeutics.
In VivoMontreal, QChttps://www.invivo.de/InVivo BioTech Services GmbH is a leading German contract manufacturing organization with more than 25 years of experience in mammalian cell culture and production of monoclonal antibodies and recombinant proteins. With the headquarter and main production facility being located on the biotech campus in Hennigsdorf, InVivo also operates a smaller, second facility in the heart of Berlin, where history started more than two decades ago. Since its inception in 1998, the company has consistently grown over time and exhibits today approximately 2 500 square meters (~ 26 900 square feet) of laboratory and operational space.
InderoMontreal, QChttps://inderocro.com/Indero offers clinical trial delivery solutions for dermatology and rheumatology, covering both early and late phase trials. Our integrated and targeted services span the world, with capabilities in North America, Europe, Latin America, and Asia-Pacific. Leveraging our relationships with investigators globally, we excel in addressing the unmet needs of immune-mediated disease studies worldwide.
Innospera PharmaMontreal, QChttps://Innospera PharmaInnospera is a privately-owned biotech company near clinical stage, developing small molecule modulators of 7-transmembrane receptors involved in a broad range of chronic and fibrotic conditions.The company’s lead drug candidates target key G-protein coupled receptors (GPCR) involved in fibroaging and inflammaging, including idiopathic pulmonary fibrosis (IPF), a condition with direshort-term prognosis. Innospera also develops multiple other modulators with promising potency in other medical conditions with pressing unmet needs.
Innova Medipharm Inc.Toronto, ONhttps://www.innovamedipharm.com/Innova Medipharm Inc. provides strategic GxP, quality and compliance services to pharmaceutical, biotech, medical device, cannabis and natural health products companies. We help our clients to solve all issues related to cGxPs.
Innovation FactoryHumilton, ONhttps://innovationfactory.ca/As a business accelerator, we are passionate about driving the growth of Ontario businesses like yours. Whether you are an entrepreneur bringing new ideas to market or a scaling business trying to get to the next level, we want to help. Innovation can happen anywhere, our goal is to make it work everywhere. We work to elevate key industry sectors including advanced manufacturing, clean tech, information technology, smart transportation, life sciences & health care and social innovations.
Innovation PEICharlottetown, PEIhttps://innovationpei.com/Our goal is to build a vibrant, diverse and growing Prince Edward Island economy by providing funding and expertise to enable strategic sectors, accelerate entrepreneurship, and foster innovation.
Innovation SaskatchewanSaskatoon, SKhttps://innovationsask.ca/Innovation Saskatchewan is the Government of Saskatchewan’s agency responsible for setting the strategic direction in research, development, science and technology. Innovation Saskatchewan work spans the operation of research and technology parks, administration of grant programs, delivery of tax incentives, and funding for research institutes, projects and partners. 
Innovative Medicine CanadaOttawa, ONSupport Orgs and Associationshttps://innovativemedicines.ca/cjulien@imc-mnc.caInnovative Medicines Canada partners to champion policies that drive the discovery, development and delivery of transformative medicines and vaccines to all Canadians to live longer and healthier lives.We achieve our goals by forming alliances, supporting policies, improving Canada’s regulatory environment, widening access to innovative medicines and ensuring the effective protection of intellectual property.
INOQuebec City, QChttps://www.ino.ca/en/Helping industries to be more productive and competitive Whether you are an equipment supplier, manufacturer, research centre or government agency, no matter what industry you are in, INO can help you develop innovative solutions tailored to your specific needs and constraints. INO can help you develop what you need when it does not exist.
Institut Universitaire de Cardiologie et de Pneumologie de QuébecQC, QCwww.laplantelab.commathieu.laplante@criucpq.ulaval.caOur research center specializes in cardiology, pneumology, and obesity-related disorders, integrating clinical and fundamental research to advance treatments, improve patient care, and shape public health strategies
Institute of Health EconomicsEdmonton, ABhttps://ihe.ca/HE sits at the intersection of academia, government, and industry – combining scientific rigour with consulting-level responsiveness. Our independent counsel enables organizations to make smart policy and investment decisions with confidence. Since 1995, we've built trusted relationships across the healthcare ecosystem, allowing us to tackle even your most complex, multi-faceted problems.
Intas Pharmaceuticalshttps://www.intaspharma.com/Intas is one of the leading multinational pharmaceutical formulation development, manufacturing and marketing companies in the world. Today, Intas is present in more than 85 countries worldwide and is growing at ~22% CAGR. Around 70% of its revenues come from the international markets, particularly the highly regulated markets of EU and US. At Intas, every day and everyone works to create a world of good health, happiness and hope.
Integrated NanotherapeuticsVancouver, BCDrug, Therapeuticintegratedntx.cominfo@integratedntx.comIntegrated Nanotherapeutics is a preclinical company, with strong preclinical POC efficacy data in NOD mice to treat Type 1 Diabetes using mRNA expressing multi-antigens and immune modulators in proprietary multi-cargo LNP.
Intelgenx corp.Montreal, QChttps://www.intelgenx.com/IntelGenx helps pharmaceutical companies improve drug delivery, provide tangible clinical and compliance benefits to patients, and manage product lifecycle by leveraging proprietary oral thin film and transdermal patch technologies.
International Microbiome Centre/University of CalgCalgary, ABhttps://imc.ucalgary.ca/The International Microbiome Centre at the University of Calgary is a translational research centre, designed to investigate the microbiome of humans, plants, animals and the physical environment. Together, world class microbiome researchers, advanced technologies and relationship building will spark groundbreaking discoveries that harness the healing power of the microbiome.
Intertek AssurisMississauga, ONhttps://www.intertek.com/Welcome to Intertek. We offer innovative solutions that encompass every aspect of life; through Assurance, Testing, Inspection and Certification (ATIC) services to our customers around the world.
Intrepid LabsToronto, ONintrepidlabs.techchristine@intrepidlabs.aiIntrepid is leveraging active machine learning, advanced robotics and deep pharmaceutical formulation expertise to accelerate the development of therapeutics and platform delivery technologies.
Invest In CanadaOttawa, ONGovernmentinvestcanada.caInvest in Canada works directly with global investors to unlock business opportunities and facilitate expansion in Canada.
Invest in HamiltonHumilton, ONhttps://investinhamilton.ca/Hamilton offers a highly skilled and diverse workforce, making it an attractive location for businesses seeking top talent. The city is home to leading educational institutions that produce graduates with up-to-date skills and industry knowledge. Hamilton’s talent pool spans key sectors such as advanced manufacturing, healthcare, technology, and life sciences, providing businesses with the expertise needed to grow and innovate. With a strong culture of continuous learning and adaptability, Hamilton’s workforce is well-equipped to meet the demands of today’s evolving economy.
Invest MississaugaMississauga, ONhttps://www.investmississauga.ca/All the right ingredients for success. We are an open and diverse city that attracts and welcomes people from around the world to live, work, study, visit and play. Discover how our city has the assets your business needs to grow and succeed.
Invest OntarioToronto, ONGovernmentinvestontario.catiffany.peever@investontario.ca; ambar.soto@investontario.caInvest Ontario is a provincial agency dedicated to securing private sector strategic business and capital investments that support economic development, resiliency and job creation in Ontario. Invest Ontario delivers a streamlined investor experience with a single point of contact and clarity throughout the process, decisions made at the speed of business in a transparent and timely manner, a suite of customizable services and supports, and coordination with municipal, regional, provincial and federal economic development organizations.
Invest QuebecMontreal, QCinvestquebec.com/international/enInvestissement Quebec International is the go-to partner for Quebec-based and foreign businesses seeking to set up or do business in the province.
Invest VancouverMetro Vancouver, BCGovernmenthttps://investvancouver.cainfo@investvancouver.caInvest Vancouver is Metro Vancouvers regional economic development service.It provides tailored services to help your business grow and expand into the Metro Vancouver region. Our team helps you navigate the regions business landscape by connecting you with key partners, arranging ecosystem tours, and providing assistance in the site selection process. We offer strategic advice, industry insights, and market intelligence to support your investment decisions.
Investissement QuebecMontreal, QChttps://www.investquebec.com/quebec/frContenus recherchés. Programme de soutien à la commercialisation et à l'exportation (PSCE). Le Programme de soutien à la commercialisation et à l'exportation (PSCE) a pris fin le 31 mars 2025. ... Il est en cours de renouvellement. Investissement Québec : Programme Impulsion PME. Impulsion PME (le « Programme ») a pour objectif d’aider les jeunes entreprises innovantes à fort potentiel de croissance à avoir accès à du capital d’investissement au stade de l’amorçage. Programme développement économique pour l'aide à la redynamisation des territoires (DEPART). L’objectif de ce Programme est de permettre aux PME de diversifier et de renforcer leurs activités économiques afin d’améliorer l’indice de vitalité économique de leur MRC, par rapport à la moyenne des autres.
iProgen Biotech Inc.Burnaby, BCDrug, Therapeuticiprogen.comklee@iprogen.comiProgen offers proprietary, modular platforms that enhances both the antibody delivery to tumor cells and antibody-receptor internalization. The platform unlocks numerous receptors that were previously overlooked or not considered for ADC development.
IRICoRMontreal, QCiricor.caclaude.larose@umontreal.caIRICoR's main objective is to bridge the translation gap between early-stage academic research and industry.
Iris CommuncationsHalifax, NVhttps://www.iriscomms.ca/Iris Communications helps clients navigate complex environments by providing integrated communications and engagement solutions.
ISEDOttawa, ONhttps://ised-isde.canada.ca/site/ised/enInnovation, Science and Economic Development Canada ( ISED ) works with Canadians in all areas of the economy and in all parts of the country to improve conditions for investment, enhance Canada's innovation performance, increase Canada's share of global trade and build a fair, efficient and competitive marketplace. We are the federal institution that leads the Innovation, Science and Economic Development portfolio.
ITR Laboratories Canada IncBaie d'Urfe, QCServices: Contract Research, Development, Manufacturingitrlab.commarketing_group@itrlab.comITR Laboratories Canada, Inc. is a GLP full service preclinical CRO located in Montreal, Canada. We support all aspects of your nonclinical development program, with focus on late-stage toxicology/IND-enabling studies.
Jenthera Therapeutics IncMontreal, QCBiotech& Pharmawww.jenthera.comlaurent.ziri@jenthera.comJenthera is a preclinical biotech developing a novel and proprietary targeted gene editing platform for the development of transformative therapeutics.
JFK Pharmaceutical
JPMORGANCalgary, Toronto, Vancouver,Montreal, AB,ON,BC,QChttps://www.jpmorgan.com/globalWe aim to be the most respected financial services firm in the world, serving corporations and individuals in more than 100 countries.
JRF Americahttps://www.jrfglobal.com/Founded in 1977, JRF Global is an Independent Research Organization, with comprehensive GLP research experience for global regulatory submissions. with the presence in several countries - US, Canada, UK, Spain, India, and Japan .
JSS Medical Rsearch IncMontreal, Saint-laurent, Westmount, QCPartners for your drug discovert, pre-clinical and clinical phasewww.jssresearch.compheessels@jssresearch.comJSS Medical Research is a full-service clinical research organization (CRO) with strong academic affiliations offering a wide range of services internationally. One of our distinguishing attributes is our methodological knowledge and expertise in the design and execution of complex clinical studies across therapeutic areas. These encompass all phases of development such as Phase I, II and III, as well as post-approval studies. The breadth of our experience enables our clients to collaborate with the same partner throughout the product lifecycle.
Kapoose Creek BioVancouver, BCDrug, Therapeutickapoosecreekbio.comeric@kapoosecreek.comKapoose Creek Bio is a platform technology company using the power AI to revolutionize the discovery of medicines from nature and has two exciting leads in optimization for indications in neurology.
Kelly Santini LLPOttawa, ONhttps://kellysantini.com/Kelly Santini LLP is a law firm in Ottawa, Ontario, founded in 1976, providing legal services to businesses, not-for-profits, insurers, and individuals. They specialize in various areas, including business law, litigation, real estate, and estate planning. The firm also emphasizes diversity and inclusion, actively promoting these values internally and externally.
Keyrus Life Science
Kingston Economic DevelopmentKingston, ONNon-Profit, Industry Association, Incubatorinvestkingston.camcilquham@investkingston.caInvest Kingston is a non-profit committed to making Kingston a leader in life sciences, merging research, healthcare and technology and supporting companies looking to enter the Canadian market
Kirby Eades Gale Baker
Kisoji Biotechnology Inc.Montreal, QCDrug, Therapeutickbimail.comgordon.ngan@kbimail.comKisoJi is a transformational antibody company that designs and engineers antibodies. Using multi-species transgenic mice to generate high affinity single domain antibodies, KisoJi uses machine learning to select and engineer multi-specific therapeutics.
Knight Therapeutics Inc.Montreal, QCDrug, Therapeuticgud-knight.com/eninfo@gud-knight.comKnight Therapeutics Inc. (TSX:GUD) is a publicly-traded, specialty pharmaceutical company focused on in-licensing or acquiring late-stage innovative prescription pharmaceuticals in Canada and Latin AmericaPlease no service provider requests.
Kompas Medical
KreaMedicaMontreal, QCkreamedica.comKRErlemann@kreamedica.comKreaMedica is a strategic investor with a collaborative drug development arm. The internal development team focuses on business assessment and program management. An existing external consultant network works with a vetted network of audited CROs.
Kye Pharmaceuticalskyepharma.cominfo@kyepharma.comKye (pronounced “kai”) is a growth-stage Canadian specialty pharmaceutical company committed to bringing value to Canadians by identifying, in-licensing, and commercializing novel prescription medicines that may not otherwise be made available in Canada
Laboratoire Riva
Launchit Solutions Inc
Laurent PharmaceuticalsMontreal, QCDrug, Therapeuticlaurentpharma.comcorporate@laurentpharma.comLate stage (Phase 2/3) clinical biotech focusing on membrane lipids modulation as a new treatment paradigm for chronic inflammation, host defense and fibrosis. Actively working on Cystic Fibrosis, IPF and Long COVID.
LaveryMontreal, QCSupport Orgs and Associationswww.Lavery.caWith a team of over 200 professionals – including lawyers, notaries, trade-mark agents and patent agents – Lavery is commited to delivering a one stop legal shop in the Province of Québec – also known as a 360º legal approach.
LEO Pharma Canada
Lexaria Bioscience Corp.
Life Sciences Nova Scotia
Life Sciences OntarioToronto, ONNon-Profit, Industry Association, Incubatorlifesciencesontario.caandy@lifesciencesontario.caLife Sciences Ontario is a fully-member funded not-for-profit association that represents the entire life sciences ecosystem in the province from industry, to service providers, academic institutions, regional governments and individual members. We support the life sciences community through advocacy, education, mentorship and networking. We also act as a platform for our members with message amplification via our various marketing channels for our member news, announcements and events; as well as acting as agents of connectivity through our various signature and monthly educational networking events. We work collaboratively with government, industry, academia and all stakeholders to foster a commercially successful life sciences sector in the province and beyond.
LifeSciences British ColumbiaVancouver, BCNon-Profit, Industry Association, Incubatorlifesciencesbc.cainfo@lifesciencesbc.caLife Sciences British Columbia is a not-for-profit, non-government, industry association that supports and represents the life sciences community of British Columbia in Canada.
LinearisQuebec City, QCSupport Orgs and Associationshttps://www.linearis.com/alex@linearis.comThrough identification of multi-omics disease signatures, we will amplify the innovation cycle in prevention, treatment monitoring and AI drug discovery companies.
LumerateToronto, ONDigital Healthlumerate.comdarren.rodenhizer@lumerate.comRaising capital is a key challenge for executives at early-stage therapeutics companies. Lumerate is launching the BioBackers investor intelligence platform to simplify the search for ideal-fit investors by helping you pinpoint firms whose specific investment interests – stage, therapeutic focus, geography, and more – align with your company's profile. Stop the ineffective random outreach and instead discover the right partners actively seeking ventures like yours, enabling meaningful connections for your next venture funding round.
Lumira VenturesToronto/Vancouver/Montreal, ON/BC/QCInvestorlumiraventures.comFounded in 2007, Lumira Ventures is a multi-stage life sciences investment firm with offices in Toronto, Montréal, Vancouver, and Boston. We partner with mission-driven entrepreneurs building companies that harness rapidly evolving advancements in medicine to develop transformative products for patients while delivering strong financial returns for our investors and meaningful economic value and impact for society.
Lupin Pharma CanadaMontreal, QCDrug, Therapeuticlupinpharma.caLupin Pharma Canada is a branch of Lupin focused on growing a Specialty Brand business in Canada. Currently specialized in GI and Women's health but looking at Respirology, Ophthalmics and Neuro .
Mammoth Health Innovation Inc.Vaughan, ONhttps://mammothhealth.org/Mammoth is primarily focused on advancing innovative technologies, especially those that target improving health outcomes. Although our original aim was to create a unique fund specifically for this, the pandemic forced us to look at other ways we could protect people during this daunting time, while still advancing innovative health technologies. Initially, these included pathogen detection, protection, and elimination.
MaRS Discovery DistrictToronto, ONNon-Profit, Industry Association, Incubatormars.commsultana@marsdd.comCanadian innovation hub overseeing a portfolio of 1200+ companies in life sciences, medical devices, climate, and enterprise software.
Matrilex Laboratories at UHTOttawa,Toronto, ONhttps://matrilex.com/MatrileX provides specialized preclinical services in the area of organ fibrosis, focusing on clinically relevant outcomes to enhance the translatability of animal model studies.
MBM Intellectual Property LawToronto,Ottawa,Vancouver,Montreal,Calgary,Hlifax, ON,BC,QC,AB,NShttp://www.mbm.com/en/mbmgeneral@mbm.comThe process of invention is complete only with the IP protection provided in law. That's where MBM comes in. We match our clients' creative thinking with the creative protection needed to achieve their goals.It's an approach that has secured us a great deal of trust over the yearstrust from our business clients in Canada and abroad; trust from our network of associates in each country around the world. They appreciate that we are dedicated solely to the practice of IP law.
McGill UniversityMontreal, QCmcgill.ca/researchjanet.prince@mcgill.caMcGill's office of Innovation and Partnership seeks partners and collaborators to further develop novel technologies. Currently, McGill has more than 300 inventions with commercial value available for licensing and development by the private sector.
McKesson CanadaSaint-Laurent, QC,https://www.mckesson.ca/McKesson Canada is a leading diversified healthcare provider supporting Canadians healthcare needs, from frontline pharmacy care and working with manufacturers to help patients navigate the complex healthcare system, to distributing more than one third of all medications in Canada and more. McKesson Canadas history and heritage dates back to the early 1900s. What started out as a national drug company has now evolved into one of the most dynamic healthcare companies in the country.
mDETECTKingston, ONDiagnostics, Devicemdetect-inc.comirsa.wiginton@mdetect-inc.commDETECT offers highly sensitive and cost-effective blood tests that can measure tumour behaviour irrespective of cancer type, stage, or context to aid in determining therapy response, resistance, and recurrence monitoring. This aims to empower clinicians to make informed treatment decisions, identify responders, optimize drug selection, and minimize exposure to ineffective therapies, ultimately improving patient outcomes. mDETECT's core technology, Methylation Detection of Circulating Tumour DNA (ctDNA), utilizes targeted next-generation sequencing (NGS) of patented DNA methylated regions specific to cancer patients, allowing for precise and quantitative measurement of tumour burden. mDETECT has developed and validated six liquid biopsies covering breast, prostate, lung, pancreatic, ovarian and colorectal cancers. The tests are high throughput, cost effective, have a quick turnaround time, are tissue naïve and can be performed in the hospital.
ME Therapeutics Holdings Inc.Vancouver, BCDrug, Therapeuticmetherapeutics.comsalim@metherapeutics.comPreclinical stage Vancouver based biotechnology company involved in the discovery and development of novel immuno-oncology therapeutics targeting immune suppression in cancer. Focussed on drugs targeting myeloid cells.
Medexus Pharma, IncToronto, ONhttps://www.medexus.com/en_USMedexus Pharmaceuticals, Inc. is a leading innovative specialty pharmaceutical company with a highly scalable North American business model based on our fully integrated infrastructure (commercial operations, supply chain, regulatory, medical affairs and salesforce) already in place and a portfolio of specialty and rare disease products that will underpin our growth for the next decade.
Medicenna Therapeutics, IncToronto, ONDrug, Therapeuticmedicenna.comfmerchant@medicenna.comMedicenna is a clinical stage immunotherapy company developing highly differentiated treatments for recurrent glioblastoma, solid tumours, autoimmune diseases and enhanced adoptive cell therapy
Mediphage BioceuticalsToronto, ONDrug, Therapeuticmediphage.cainfo@mediphage.bioMediphage is utilizing its proprietary and scalable E. coli-based manufacturing process to manufacture ministring DNA (msDNA), which is a linear, high fidelity, and covalently closed double-stranded DNA vector.
Medlior Health Outcomes Research LtdCalgary, ABmedlior.comtara.cowling@medlior.com
Medlior Health Outcomes Research LtdCalgary, ABDrug, Therapeutic, Diagnostics, Device, Digital health Service, Contreact Research, Development, Manufacturingwww.medlior.comtara.cowling@medlior.comMedlior is an independent research consultancy specializing in health outcomes and real-world evidence (RWE). We help life sciences companies generate robust, data-driven insights to accelerate market access and inform healthcare decision-making. With unique access to Albertas comprehensive health system data, Medlior delivers trusted evidence across the product lifecycle.
Merck Canada IncMontreal, QCDrug, Therapeuticmerck.ca/enFor over 130 years, Merck Canada has been providing leading innovations and therapies for many of our world's most challenging diseases in pursuit of our mission to save and improve lives.
Microbion Pharma Corp.Vancouver, BCTherapeuticswww.microbioncorp.com investors@microbioncorp.comMicrobion is a clinical stage biotechnology company dedicated to the development of its proprietary antimicrobial, anti-biofilm family of compounds as therapeutic agents for the treatment of infectious diseases, including those caused by antibiotic-resistant bacteria. Our lead drug candidate, pravibismane, is the first in a new class of anti-infectives. We have successfully completed three Phase 1 clinical studies to evaluate the safety of a topical/local formulation of pravibismane (MBN-101) in healthy volunteers. Subsequently, two additional clinical studies have been completed: a Phase 2a clinical study to evaluate the safety and efficacy of MBN-101 for the treatment of post-surgical orthopedic device-associated infections and a Phase 1b study to assess safety and preliminary efficacy of MBN-101 for treatment of moderate-to-severe diabetic foot ulcer (DFI) infections.
Ministere de lEconomie, de lInnovation et de lEnergieMontreal, QChttps://www.economie.gouv.qc.ca/
Ministry of Economic Development, Job Creation and TradeToronto, ONhttps://www.ontario.ca/page/ministry-economic-development-job-creation-tradeOur engaged and inclusive team is passionate about delivering policies, programs and services to help businesses of all sizes and in every region to start, grow, invest, trade and create jobs, and to attract investment to Ontario.
MisproMontreal, QCPartners for your drug discovert, pre-clinical and clinical phasewww.mispro.comytessier@mispro.comMispro is an AAALAC-accredited contract vivarium organization (CVO) that operates a network of full-service turnkey vivarium research facilities where biosciences companies of all sizes and therapeutic indications can conduct preclinical in vivo rodent studies with the support of Mispro’s animal care and regulatory compliance oversight services. Mispro was founded in Montréal and also has locations in all major U.S. biotech hubs.
ModernaToronto, ONDrug, Therapeutichttps://www.modernatx.com/en-CAleslie.madden@modernatx.comModerna in Canada. Moderna is a pioneer in mRNA science and a leading biopharmaceutical company in Canada, focused on transforming the way we prevent and treat disease. Since establishing its Canadian presence, Moderna has played a critical role in public health, including delivering one of the earliest and most effective COVID-19 vaccines. The company continues to invest in Canadas health and innovation ecosystem through local partnerships, clinical research, and advanced manufacturing. As part of Modernas global mission, the Canadian team contributes to a robust pipeline of mRNA-based therapeutics and vaccines targeting infectious diseases, cancer and rare diseases.
Modulari-T BioscienceMontreal, QChttps://modularit.bio/Our proprietary Modular Actuation Receptor Cells (MARC) harness the natural architecture of immune receptors to create a superior immunotherapy against cancer and autoimmune diseases. Modular Vectors (MoVe) enable effective in-vivo delivery
Molecular ForecasterMontreal, QCPartners for your drug discovert, pre-clinical and clinical phasehttps://www.molecularforecaster.comjosh.pottel@molecularforecaster.comMolecular Forecaster accelerates small-molecule drug discovery through expert computational chemistry services and intelligent software. Our all-in collaborative approach helps partners optimize compounds faster and de-risk early drug design decisions
Monbel Consultants Inc.Montreal, QChttps://www.monbeltech.com/Notre firme de gnie-conseil offre un large ventail de services en industrie pharmaceutique & biotechnologique. Avec notre stratgie daffaire flexible, nous offrons une mobilisation rapide des ressources et une excution transparente.
Montréal InternationalMontreal, QCSupport Orgs and Associationsmontrealinternational.comlea.genest@mtlintl.comGreater Montréal’s economic promotion agency, for the past 25 years, Montréal International (MI) has contributed to building Greater Montréal’s international reputation and prosperity by acting as a driving force for economic development.
Montreal InVivoMontreal, QCSupport Orgs and Associationshttps://www.montreal-invivo.com/sdoyle@montreal-invivo.comMontréal InVivo represents the Life sciences and Health Technologies (LSHT) cluster of Greater Montréal. We are a non-profit economic development organization that aims to create a business environment that fosters innovation, growth, and competitiveness of public and private organizations within the LSHT sector
Morphocell Technologies IncLaval, QCBiotech& Pharmawww.morphocell.comv.ling@morphocell.comMorphocell Technologies is a regenerative medicine company developing an extensive therapeutic platform based on its stem cell-derived engineered tissues for organ replacement therapy. Through an allogeneic approach, strong preclinical data in small and large animals and key hurdles in manufacturing already de-risked, Morphocell is rapidly approaching the clinical phases. ReLiver®, our lead product, is an implantable, fully mature, engineered liver tissue that allows for the allogeneic treatment of acute and acute-on-chronic liver failure (a $14B market), without the need of immunosuppression. Supported by a $40M series A round and strong partnerships, ReLiver is now less than 30 months away from a first-in-human clinical trial. With 24 FTE, a solid IP position and new state-of-the-art HQ and laboratories, Morphocell established its leadership in the liver cell therapy space.
My VivaEdmonton, ABmyvivainc.comloreen@revivewellness.caMy Viva Plan is transforming healthcare through an AI-powered digital platform that makes lifestyle medicine scalable, personalized, and effective. Designed for both clinicians and patients, the platform helps prevent and manage chronic conditions like obesity, diabetes, and heart disease.
NanofacileMontreal, QCPartners for your drug discovert, pre-clinical and clinical phasewww.nanofacile.bioruben.lopez@nanofacile.bioNanofacile accelerates RNA therapy development by providing biotech innovators with intuitive, easy-to-use tools for preclinical research and high-throughput screening. Our sterile, standalone consumables streamline formulation workflows, enabling faster and more efficient RNA therapy optimization.
NanoVation TherapeuticsVancouver, BCnanovationtx.comj.kulkarni@nanovationtx.comNanoVation Therapeutics (NTx) is a gene therapy company developing customizable next-gen lipid nanoparticle technologies. Our formulations display increased accumulation in extrahepatic tissues and can be tuned to specific applications.
National Research Council CanadaOttawa, ONnrc-cnrc.gc.ca/eng/rd/hhtalexandre.serrano@nrc-cnrc.gc.caCanada's premier research organization
Neolys PharmaQuebec City, QChttps://neolyspharma.ca/en/info@neolyspharma.caOur mission is to develop new treatments for cancers that are particularly difficult to treat with the current therapeutic arsenal, and which are behind a large number of deaths every year in Canada.
Neomabs BiotechnologiesMontreal, QCneomabsbio.comcatherine.gagnon@neomabsbio.comNeomabs Biotechnologies, a company dedicated to developing new immunotherapies for cancer treatment launches in Montreal.
Neopharm LabsBlainville, QCPre clinicalneopharmlabs.combalt@neopharmlabs.comAt Neopharm our team of experts, equipped with cutting-edge technology and unwavering dedication, work tirelessly to transform our clients' visions into reality. As trusted partners to leaders in the pharmaceutical and life sciences industry, we're driven by a passion to improve the lives of the global community.
NervGen PharmaVancouver, BCDrug, TherapeuticDrug, Therapeuticnervgen.comNervGen Pharma Corp. is a clinical stage biotech company dedicated to developing innovative treatments that enable the nervous system to repair itself following damage, whether due to injury or disease.
Neurenati Therapeutics Inc.Montreal, QCneurenati.commaxime@neurenati.comNeurenati Therapeutics is a pioneering biotechnology company developing an innovative treatment for Hirschsprung disease.
Niagara Economic Development CorporationThorold, ONhttps://niagaracanada.com/Niagara is committed to working together to support our business community. Our 12 municipalities work as one to make sure our businesses have what they need through thick and thin.
NL Health ServicesSt. John's, NLhttps://nlhealthservices.ca/As the provincial health authority, NL Health Services is responsible for providing health care across Newfoundland and Labrador. Our goal is to create a health-care system that is more integrated, accessible, technologically enhanced, equitable and sustainable for everyone in the province. By operating under one unified provincial authority, we can streamline services, improve efficiency and work toward better health outcomes for all people of the province.
NMX Research & SolutionsLaval, QChttps://www.nmxresearch.com/NMX Research & Solutions Inc. is a pioneering Contract Research Organization (CRO) specializing in Fragment-Based Drug Discovery (FBDD) and biophysical screening technologies.
Noa TherapeuticsToronto, ONDrug, Therapeuticnoatherapeutics.comcarlaspina@noathera.comNoa Therapeutics is a preclinical biotech company pioneering the development of homeostatic modulating small molecules, targeting barrier resolution, to effectively modify pathogenic drivers of inflammatory diseases. Adopting a systems biology and computer-assisted discovery approach, Noa is establishing a novel small molecule platform for the tailored treatment of immune diseases involving barrier dysfunction to address unmet needs in over $100B of inflammatory disease markets.
Nomic BioMontreal, QChttps://www.nomic.bio/Nomic has an outstanding analysis suite, with a great support team who will jump on a call and guide you through all its organizational and graphing capacities, and unmatched comprehensiveness with hundreds of cytokines and other soluble factors all measured at once, really maximizing the information obtained from precious samples.
North Forge Technology ExchangeWinnipeg, MBNon-Profit, Industry Association, Incubatorhttps://northforge.ca/jfoster@northforge.caNorth Forge Technology Exchange is a non-profit incubator accelerator that works with startups across Canada and globally in technology, STEM, and advanced manufacturing from the ideation stages through to acceleration. They fuel Canadas innovation economy, providing founders with experienced mentors, entrepreneurs-in-residence, award-winning growth coaches, and a unique, online four-stage Founders program. They have worked with over 350 companies and have created over 1,900 jobs. Armed with North Americas largest non-profit fabrication lab (FabLab), they operate out of 35,000 square feet across Innovation Drive and Innovation Alley in Winnipeg, Manitoba. North Forge is also a designated incubator by the IRCC for the Start-up Visa Program.
Northern Alberta Clinical Trials and Research CentreEdmonton, ABnactrc.calricher@ualberta.ca
Northern RNA Inc.Calgary, ABnorthernrna.comtmorgan@northernrna.comNorthern RNA Inc. is a Canadian CDMO specializing in the production of nucleic acid products.
Norton Rose Fulbright Canada LLPOttawa, ONhttps://www.nortonrosefulbright.com/en-caNorton Rose Fulbright is a global law firm with a deep commitment to our clients, their industries and our people. Thats what makes us a powerful, trusted advisor to global and local organizations the world over.
Norvell JeffersonVancouver, BChttps://www.norvelljefferson.com/Imagination creates the new. Exceeding your expectations and ensuring you value with undeniably unique content that captivates your audience.
NospharmaMontreal, QCDrug, Therapeuticnospharma.caanmol@nospharma.caDistrict 3 Innovation is an Montreal incubator supporting 9 startups at BIO. They are us supported onsite by Anmol Nagpal, CEO of Nospharma and our EIR. D3 Teams: https://rb.gy/kniq5h*Nospharma is scheduling 1on1s on this profile (see Description)*
Notogen, Inc.Toronto, ONhttps://notogen.com/Notogen is a biotechnology company focused on treating back and neck dysfunction caused by spinal disc degeneration. Our lead product, NTG-101, is a targeted, non-surgical, non-cellular treatment for degenerative disc disease.
Nova Scotia GovernmentHalifax, NShttps://beta.novascotia.ca/
Nova Scotia Health AuthorityHalifax, NShttps://www.nshealth.ca/The Nova Scotia Health Innovation Hub is dedicated to exactly this. A first-of-its-kind centre of excellence for health research and innovation in Atlantic Canada, were leading health care thinking to deliver better solutions for patients and providers. Through strategic partnerships with patients and families, clinical champions, industry, health care foundations, governments, and academic partners, we are working to transform health care through the best available evidence and well-researched solutions.
Novatek International IncMontreal, QCPartners for your drug discovert, pre-clinical and clinical phasewww.ntint.comvicky.azadian@ntint.comEstablished in 1996, Novatek’s mission is to help pharmaceutical companies and other life science organizations leverage their investment in information technology and quality processes by reducing cost, improving productivity, and enhancing compliance. With over 25 years of user experience and developer level technical support, simple or complex installations are seamless and rapid.
Novateur Ventures Inc.Vancouver, BCDrug, Therapeuticnovateur.orgjulia@novateur.orgNovateur Ventures is supporting Virogin Biotech for partnering of their lead asset, VG161. Virogin is a clinical-stage Canadian immuno-oncology company developing a pipeline of cancer vaccines, oncolytic viruses, and mRNA therapeutics.
Novo Nordisk Canada Inc.Mississuaga, ONhttps://www.novonordisk.ca/We are a global healthcare company, founded in 1923 and headquartered just outside Copenhagen, Denmark. Our Canadian headquarters is based in Mississauga, Ontario.Our purpose is to drive change to defeat serious chronic diseases, built upon our heritage in diabetes. We do so by pioneering scientific breakthroughs, expanding access to our medicines and working to prevent and ultimately cure the diseases we treat.
Novocol PharmaCambridge, ONnovocolpharma.comelee@novocolpharma.comNovocol Pharma is a global leading CDMO in sterile injectable cartridge fill finish and combination products device assembly.
Nucliq Biologics IncSt. John's, NLhttps://nucliqbio.ca/At Nucliq Biologics, we are pioneering a new era in precision medicine where microbiome intelligence meets AI to power truly personalized therapeutics. Our proprietary platform, Microterra AI, transforms Gutcheck-derived insights and multi-omics data into actionable drug discovery.
Nucliq Biologics Inc.St. John's, NLDrug, Therapeutic,Diagnostics, Device,Digital Healthwww.nucliqbio.canikitha@nucliqbio.caAt Nucliq Biologics, we are committed to empowering individuals with microbiome insights to help them take control of their health. By addressing microbiome dysbiosis, we enable people to make informed dietary and lifestyle choices to overcome symptoms that impact their overall well-being. Beyond diagnostics, we are pioneering the development of therapeutics targeting neurological dysfunction, leveraging cutting-edge microbiome science to create innovative, life-changing solutions. Through trust, transparency, and scientific excellence, we strive to advance health and revolutionize microbiome-based interventions for a healthier future.
Nucro-TechnicsScarborough, ONServices: Contract Research, Development, Manufacturingnucro-technics.comcfanaras@nucro-technics.comNucro-Technics is a full-service Contract Support Organization that specializes in the conduct of both GLP and GMP studies and is looking to guide companies beginning at the non-clinical Investigational New Drug (IND) phase, through to CMC, and product release testing. Nucro-Technics’ many services include: pre-clinical toxicology; genetic toxicology; bioanalytical services; chemistry/microbiology analysis/method development; and consulting to the biotech, pharmaceutical and medical device industries. Their organization is routinely audited by Health Canada and the US FDA.
OCT Biopharma Inc
Office of Life Sciences and Biomanufacturing ReadiToronto, ONhttps://new.geds-sage.gc.ca/en/GEDS/
OLSBROttawa, ONacademic, non-profit
OMERS Life SciencesToronto, ONInvestoromers.combwu@omers.comRoyalty and Structured Financing
OmniaBio Inc.Hamilton, ONServices: Contract Research, Development, Manufacturingomniabio.comcdmo@omniabio.comOmniaBio (a subsidiary of CCRM) is a cell and gene therapy CDMO offering process development and GMP manufacturing services across iPSCs and other stem cells, immunotherapies (including T, NK, CAR-T, and CAR-NK), and viral vectors (including LVV).
Omnium GlobalToronto, ONServices: Legal, Consulting, Businessomnium-global.cominfo@omnium-global.comOmnium Global’s vision is to accelerate timelines to market for an impact on global health by helping companies beat the odds of success in biotech. From strategy inception to seamless business operations, partner with biotech and life science companies, CDMOs, and investors for the full commercialization process. When it comes to complex biologics and advanced therapies, Omnium Global believes no challenge is too big in process intensification, CMC compliance, outsourcing, procurement, or facility design.
ONBIO Inc.Richmond, ONhttps://www.onbio.net/We primarily provide pharmaceutical chemicals for use in the life science industry. Our regulated products are manufactured in compliance with current ICH/Q7A guidelines and are in full compliance with cGMP. The regulated products are manufactured in facilities that are inspected and licensed by the local health authority, for example the US FDA, EMA or Health Canada
Oncolytics Biotech Inc.Calgary, ABhttps://oncolyticsbiotech.com/At Oncolytics, we are driven to improve the lives of people with cancer by giving them what matters most: more quality time. To do this, we are developing pelareorep, a unique immunotherapy with the power to awaken the immune system and unlock its antitumor potential. Pelareorep is delivered intravenously and is systemically active, setting it apart from other immunotherapies that must be injected into the tumor.
Ontario Bioscience Innovation Organization (OBIO)Toronto, ONobio.cainfo@obio.caOBIO® is a not-for-profit, life sciences and health tech accelerator engaged in the development of venture-backed Canadian companies as they raise capital from international VC and strategic partners.
Ontario Brain InstituteToronto, ONNon-Profit, Industry Association, Incubatorhttps://www.braininstitute.ca/bpickard@braininstitute.caThe Ontario Brain Institute (OBI) is a provincially funded, not-for-profit organization that accelerates discovery and innovation, benefiting both patients and the economy. OBI's collaborative team science approach promotes brain research, commercialization, and care by connecting researchers, clinicians, industry, patients, and their advocates to improve the lives of those living with brain disorders. For more information, visit braininstitute.ca
Optigo Biotherapeutics Inc.Vancouver, BCBiotechnology, Therapeutics www.optigobio.cominfo@optigobio.comOptigo Biotherapeutics is an innovative pre-clinical stage biotherapeutics company working to develop cutting-edge treatments to address vision loss from chronic ophthalmic diseases, many of which are currently treated by monthly or bimonthly injections of drugs into the eye(s) by a retina specialist.We believe that by reducing the frequency at which each dose of drug is delivered, we will reduce the inconvenience, discomfort, risk and expense of existing treatments. In doing so, we hope to reduce the number of patients dropping out of their treatment cycles or having to skip doses due to inconvenient timing.
Organon & Co.Kirkland, QChttps://www.organon.com/canada-en/Organon is a global healthcare company formed through a spinoff from Merck (known as MSD outside of the U.S. and Canada) with a mission to deliver impactful medicines and solutions for a healthier every day. We build upon our strong foundation of more than 60 medicines and other products across a range of areas including reproductive health, immunology, cardiovascular disease, dermatology, allergies and asthma.
Osler, Hoskin & HarcourtOttawa,Toronto,Montreal, Calgary, ON,QC,ABhttps://www.osler.com/en/Osler is a leader in Canadian business law with a singular focus your business. With an integrated network of offices in Toronto, Montral, Calgary, Ottawa, Vancouver and New York, we have an undisputed reputation for solving problems, removing obstacles, and providing the answers you need, when you need them.
Osler, Hoskin & Harcourt LLPOttawa, ONService:Legal,Consulting,Business Investorwww.osler.comswhite@osler.comOsler is a leader in Canadian business law with a singular focus your business. With an integrated network of offices in Toronto, Montral, Calgary, Ottawa, Vancouver and New York, we have an undisputed reputation for solving problems, removing obstacles, and providing the answers you need, when you need them. Osler is recognized for the breadth and depth of its practice in business law and is consistently ranked as one of Canadas top firms. Proactive, pragmatic, experienced, innovative and collaborative, our team of over 500 lawyers is driven by the specific needs of our clients. At Osler, we do everything it takes to maintain our position as one of Canadas leading business law firms
Otsuka CanadaMontreal, QCBiotech& Pharmahttps://otsukacanada.com/maxime.rouleau@otsuka-ca.comOtsuka Canada Pharmaceutical Inc. (OCPI) is an innovative, fast-growing health care company that commercializes Otsuka medicines in Canada, with a focus on commitment to neuroscience, and nephrology. OCPI is dedicated to improving patients’ health and the quality of human life.
Oxford Properties GroupToronto, ONhttps://www.oxfordproperties.com/We are a leading global real estate investor, developer and manager that combines our capital with our capabilities to create real estate that strengthens economies and communities.
PacificanVancouver, BChttps://www.canada.ca/en/pacific-economic-development.htmlPacific Economic Development Canada (PacifiCan) is the dedicated federal economic development agency for British Columbians.
Pacylex Pharmaceuticals Inc.Edmonton, ABDrug, Therapeuticpacylex.commichael.weickert@pacylex.comPacylex is developing zelenirstat, a first in class, oral cancer treatment in Phase 2a for NHL and colorectal cancer. Zelenirstat disrupts EGFR, VEGFR, cancer cell signaling, cancer OXPHOS, and more, by targeting the underlying biology, myristoylation.
Pangaea GroupOakville, ONServices: Contract Research, Development, Manufacturingpangaea-consultants.comjmartens@pangaea-consultants.com or MLafoley@pangaea-consultants.comPangaea Group is a boutique consulting company that has focused on the Canadian Healthcare Industry for over 25 years. Our expertise has helped over 30 International Pharmaceutical companies establish their commercial footprint in Canada.
Paperplane TherapeuticsGranby, QChttps://paperplanetherapeutics.com/Paperplane Therapeutics is at the forefront of developing virtual reality therapies that revolutionize patient care by effectively managing pain and anxiety in healthcare settings.
Paradox ImmunotherapeuticsToronto, ONDrug, Therapeuticparadoximmuno.comnatalie@paradoximmuno.comParadox Immunotherapeutics is a biotech addressing the global burden of protein misfolding diseases—devastating conditions with limited treatment options and high mortality. Backed by a team with a proven track record, including the design of an antibody that led to a $1.2B acquisition deal in 2021, Paradox uses a proprietary platform that requires only the native protein structure to develop antibodies that selectively deplete pathological proteins and currently has 3 new candidates ready to disrupt the protein misfolding industry.
PARLEE MCLAWS LLPEdmonton, ABhttps://www.parlee.com/At Parlee McLaws we are committed to service and to delivering sound, strategic legal solutions. We take pride in knowing our clients' industries, understanding their concerns and providing practical advice. Its an approach that has allowed us to build relationships based on trust, respect and results.
Partner InternationalDartmouth, NSServices: Legal, Consulting, Businesspartner-intl.cominfo@partner-intl.comPartner International is a leading outsourced business development company, focused on partnering, licensing, and M&A transactions globally.
PatsnapToronto, ONhttps://www.patsnap.com/Since 2007, our mission is to empower R&D and IP teams to unlock insights, accelerate discoveries, and protect breakthroughs with unprecedented speed and precision. Smart AI agents, the most comprehensive innovation database, robust APIs, and AI-powered SaaS all at your fingertips.
PCK Intellectual PropertyToronto, ONhttps://www.pckip.com/Founded by visionaries Stephen Perry and Andrew Currier, and grown by a dedicated and skilled team, PCK has become one of Canadas leading independent intellectual property firms. For over two decades, weve delivered cutting-edge legal solutions to clients around the globehelping businesses of all sizes protect, manage, and elevate their intellectual property portfolios.
PEI BioallianceCharlottetown, PENon-Profit, Industry Association, Incubatorpeibioalliance.comrory@peibioalliance.comThe Prince Edward Island Bioscience Cluster is a Canadian centre of expertise in health product development and biomanufacturing, from APIs to biologics and natural product chemistry, with applications in human health, veterinary products and fish health.
PendopharmMontreal, QCBiotech& Pharmawww.pendopharm.comjisber@pharmascience.comPendopharm, a division of Pharmascience, is a leading Canadian specialty pharmaceutical company dedicated to developing, in-licensing and commercializing innovative products to improve the lives of Canadian patients and their families.
Pfizer Canada, IncKirkland, QChttps://www.pfizer.ca/enPfizer Canada is the Canadian operation of Pfizer Inc., one of the world's leading biopharmaceutical companies.We strive to profoundly impact the health of Canadians through the discovery, development and delivery of medicines and vaccines.
Pharma insilica (Biomark)Quebec City, QCBiotech& Pharmahttps://pharma-insilica.com/haincejf@pharma-insilica.comPharma in silica is a preclinical-stage company developing a well-tolerated chemotherapy treatment for lung, breast and proprietary drug-development other solid cancers. The company deploys a /manufacture platform based on novel silica-made nanocarriers enhancing safety & e?cacy of cytotoxic molecules.
Pharma Medica Research Inc.Toronto, ONhttps://www.pharmamedica.com/#HomePharma Medica Research Inc. (PMRI) was founded in Toronto, Canada in 1997 and is a privately held Clinical Research Organization (CRO). We are owned and operated by a very hands-on, scientific, and involved leadership team.
Pharmaplanter Technologies IncBurnaby, BChttps://pharmaplanter.com/PharmaPlanter Technologies Inc. is a biotechnology company with a mission to develop products and technologies to improve people's health.
PharmascienceMontreal, QCBiotech& Pharmawww.pharmascience.comdgoodman@pharmascience.comSince 1983, Pharmascience has been a leading manufacturer of generic, branded, and over-the-counter pharmaceuticals, serving both the Canadian and international markets. With product distribution in over 50 countries, we provide 1,300 skus to pharmaceutical wholesalers, hospitals, and pharmacists. Our facilities produce more than 5 billion dosage units of medicines every year.
pharmBDMontreal, QCpharmbd.cominfo@pharmbd.comPharmBD represents different lifescience companies and partners carrying portfolio of clinical stage or market-ready products for out-licensing in various markets. We are actively seeking partners, please check out our asset portfolio for more info.
PHARMDSIDE INC.Laval, QCpharmdside.cominfo@pharmdside.comseeking commercial and late stage in-licensing or acquisition of products for the Canadian and Eastern Central European markets. Clients include Bausch Health Canada
Pharmdside Strategic Business AdvisorsMontreal, QChttps://www.pharmdside.com/PHARMDSIDE is a consulting and advisory firm providing strategy, business development and M&A services to the healthcare industry. We bring the agility of a boutique advisory firm with the experience of a large one.
PHEBRA PTY LIMITEDMontreal, QChttps://www.phebra.com/cae/Phebra has a long history of innovative research, pharmaceutical development and manufacturing of critical medicines, including emergency injectables, antidotes and other small volume parenterals. Together with manufacturing medicines, Phebra is a trusted and reliable partner to hospitals seeking development of sought after treatment solutions for their patients. Similarly, Phebra Canada commercialize products based on compassion and a drive to help and looks forward to working closely with the Canadian community, to bring therapies to patients that save and significantly improve their lives.
Porter O'BrienFredericton, NBhttps://www.porterobrien.com/info@porterobrien.comBased in New Brunswick, Porter OBrien is proud to offer a full suite of management consulting and communications services through our own staff and our nationwide network of trusted associates
PragmaClin Research Inc.St. John's, NLDiagnostics, Device,Digital Healthwww.pragmaclin.combronwyn@pragmaclin.comPragmaClin is transforming neurological care with PRIMS, our digital assessment platform that uses depth cameras and AI to track motor symptoms in conditions like Parkinsons Disease. PRIMS not only enhances clinical care by providing objective, data-driven insights for patient management, but it also brings value to clinical research. Our platform enables precise tracking of motor symptoms as digital endpoints, supporting real-world data collection and streamlining recruitment and monitoring for trials. By bridging clinical care and research, PRIMS empowers healthcare professionals and pharma partners to advance treatment outcomes and discover new therapies for neurological conditions.
Pramana Pharmaceuticals Inc.Vancouver, BCTherapeuticswww.pramanapharma.cadiane@pramanapharma.comPramana Pharmaceuticals Inc., is focused on cardiometabolic disease. Pramana has discovered and developed a novel small molecule platform that powers a new mechanism of action to treat metabolic dysregulation. The company's development program is led by a world class big pharma multi functional scientific team with a strong track record of drug success.
Pre-Amphttps://www.preampbio.com/
ProdulithBoucherville, QChttps://produlith.com/Bienvenue chez Produlith, une entreprise familiale base sur la Rive-Sud de Montral, spcialise depuis plus de 40 ans dans limpression de botes pliantes, dtiquettes et demballages flexibles.
ProMIS NeurosciencesToronto, ONhttps://www.promisneurosciences.com/ProMIS Neurosciences is a clinical-stage biotechnology company committed to the discovery and development of therapeutic antibodies selective for toxic oligomers associated with the development and progression of neurodegenerative and other misfolded protein diseases. Using our proprietary target discovery engine, EpiSelect, we can predict novel targets known as Disease Specific Epitopes (DSEs) on the molecular surface of misfolded proteins that cause neurodegenerative and other misfolded protein diseases, including Alzheimers disease (AD), amyotrophic lateral sclerosis (ALS), frontotemporal dementia (FTD), multiple system atrophy (MSA), and Parkinsons Disease (PD). We have offices in Cambridge, Massachusetts (USA) and Toronto, Ontario (CAN).
ProteinQure Inc.Toronto, ONDrug, Therapeuticproteinqure.comlucas@proteinqure.comProteinQure has built the best computational platform for designing peptides for extra-cellular targets. Their lead program for TNBC will dose the first patient in Q3 2025 at the best hospitals in NA. Their platform has been validated (in-vivo and with unprecedented in-vitro characteristics) with three top 25 pharma companies in their experimental assays. ProteinQure is the only computational platform capable of designing peptides with the full complement of non-canonical amino acids, so that their peptides are 100x better than natural peptide ligands. For their own internal programs they use the novel peptides to help deliver payloads in a tissue specific manner. Peptides are ideal for delivery of different payloads like radioisotopes and gene therapy since they are tissue specific and easier to manufacture. They also have exciting in-vivo POC for siRNA delivery to CNS.
Providence TherapeuticsCalgary, ABhttps://providencetherapeutics.com/Providence Therapeutics Providence Therapeutics is a mRNA medicines company developing transformative vaccines for cancer treatment and protection from hard-to-treat infectious diseases.
Province of Nova Scotia
Province of Prince Edward Island
QReserveHamilton, ONDigital Healthqreserve.comgraeme.brown@qreserve.comQReserve provides powerful enterprise-grade scheduling and resource management software to world-class universities, hospitals, and life science companies globally. QReserve’s configurable cloud platform facilitates management of valuable equipment, spaces (rooms/desks), people, and services, replacing inefficient manual methods. They automate complex workflows and provide critical utilization data to optimize resource use, inform investment decisions, and demonstrate value. Maximize efficiency and gain crucial insights with QReserve's secure, scalable solution, tailored for complex research and facility management environments.
Québec InternationalQuebec City, QCSupport Orgs and Associationshttps://www.quebecinternational.ca/jmgarro@quebecinternational.caQuébec International promotes Québec City's economic growth and global presence, collaborating with partners worldwide to support entrepreneurs, professionals, and investors by overcoming obstacles and guiding development.
Quality & Compliance Services Inc.Mississauga, ONServices: Legal, Consulting, Businessqualityandcompliance.cominfo@qualityandcompliance.comQ&C is the largest full-service consultant and importer for Health Canada regulated products. With 30 years of experience, we provide expert regulatory and compliance consulting for importing drugs, APIs, NHPs and medical devices into Canada
Quebec Government
Queen's University
QurCan Therapeutics Inc.Toronto, ONqurcan.comma.amini@qurcan.com
Rakovina TherapeuticsVancouver, BCDrug, Therapeuticrakovinatherapeutics.cominfo@rakovinatherapeutics.comRakovina Therapeutics Inc. (TSX-V: RKV) is focused on the discovery and development of new cancer treatments based on novel DNA-damage response targeting agents using proprietary Deep Docking(TM) AI algorithm.
Raya Therapeutic, Inc.MontrealDrug, Therapeuticrayatherapeutic.comadmin@rayatherapeutic.comRaya is focused on developing drugs to treat ALS. The company has secured 5 clinical stage compounds (all NCEs) with different MOAs that all have potential to treat ALS. The company is planning to start a dedicated P3 Platform Trial in Q1 of 2025.
RBCx
RejuvenRx Inc.
Research ManitobaWinnipeg, MBServices: Contract Research, Development, Manufacturinghttps://researchmanitoba.ca/jennifer.cleary@researchmb.caResearch Manitoba is the provincial research agency that promotes, supports, and coordinates the funding of research excellence and innovation in health, natural and social sciences, engineering and the humanities in Manitoba. Research Manitoba supports local talent development by providing research support to early career researchers and graduate students, along with fostering strategic partnerships to strengthen research and innovation in Manitoba.
Reverb TherapeuticsVancouver, BCTherapeutics www.reverbtx.com info@reverbtx.comReverb Therapeutics is advancing its Amplifier platform: a novel approach for cancer treatment, promoting targeted immune activation while limiting toxicity.
Rhythm Biotherapeutics Inc
Riches, McKenzie & Herbert LLP
Ring Rescue Inc
Ripple Therapeutics Corporation
ROBIC
ROBIC IP AGENCY LP
Roche CanadaMississauga<, ONBiotech& Pharmahttps://www.rochecanada.com/fr/homenatalie.verreault@roche.comThroughout our 125-year history, Roche has grown into one of the world’s largest biotech companies, as well as a leading provider of in-vitro diagnostics and a global supplier of transformative innovative solutions across major disease areas. Our commitment to our people, partners, stakeholders and, most importantly, our patients remains as strong as it was on the first day of our journey.
Roots pharmaceutical
Ropack
Ropack Pharma Solutions
Royalmount LaboratoriesMontreal, QCPartners for your drug discovert, pre-clinical and clinical phasehttps://royalmountlaboratories.compskoutel@pharmascience.comFor over 30 years, Pharmascience Royalmount Laboratories has been conducting regulated and non-regulated bioanalysis. With over 300 FDA/EMA/HC compliant bioanalytical methods, and industry’s highest reliability / lowest reanalysis rates of <2%, this makes us a great, cost-effective, partner-of-choice for your bioanalytical programs
Rubicon Strategy
Rural Manitoba Economic Development CooperationWinnipeg, MBNon-Profit, Industry Association, Incubatorhttps://rmedcorp.ca/alexander.lavoie@rmedcorp.caThe Rural ManitobaEconomic Development corporation (RMED) is a non-profit organisation dedicated to advancing economic growth and innovation in rural Manitoba. RMED collabortaes with local government, businesses, and economic development agencies to support community-driven initiatives. by providing strategic guidance, data analysis, and access to government programs, RMED empwers rural communities to attract investment, create jobs, and enhance competitivenss. Through partnerships and tailored resources, RMED plays a pivotal role in fostering sustainable developmentacross the province.
Saguaro Technologies
Sandoz Canada
Sanofi's Vaccine Business
Santé Québec
SciLeads
Scimega
Scimega Recherche IncLaval, QCPartners for your drug discovert, pre-clinical and clinical phasewww.scimega.comjulie@scimega.comScimega is a niche Canadian oncology CRO acting in Canada within the context of global cutting-edge oncology trials sponsored by U.S. mid-size and smaller biotechs.
Sciteline
Searchlight Pharma Inc.Montreal, QCDrug, Therapeuticsearchlightpharma.cainfo@searchlightpharma.ca*No service providers please*Searchlight Pharma is a Canadian-based specialty healthcare company dedicated to improving human health and wellness through the acquisition, commercialization, and focused development of unique healthcare products.
Seeker Labs Inc.
SGS Life Sciences
Shadow Lake Group
Shared HealthWinnipeg, MBServices: Contract Research, Development, Manufacturinghttps://hsc.mb.ca/pbeaudin@sharedhealthmb.caHealth Sciences Centre- Research Department encourages and support programs of clinical / healthcare research at the Health Sciences Centre, which advance the state of medical knowledge, enhance the health of residents of Manitoba and support the development of technology transfer and commercial application opportunities within Manitoba. The Department of Research strives to provide a safe, comfortable and supportive infrastructure for research while integrating accepted ethical values as expressed by the University of Manitoba Research Ethics Board.
SimmunomeMontreal, QCBiotech& Pharmawww.simmunome.comtanya.tolomeo@simmunome.comSimmunome is a TechBio company enhancing the predictability of clinical drug development to prevent late-stage failures by predicting patient outcomes sooner, for every patient.
Simon-Kucher & Partners
Sixty Degree Capital
Smart & Biggar, LP
Somru Bioscience Inc.Charlottetown, PEServices: Contract Research, Development, Manufacturingsomru.camoin@somrubioscience.comOur company, located in PEI, Canada, specializes in providing bioanalytical and characterization services for large molecule therapeutics. We have advanced technology platforms including Flow Cytometry, ELISpot, PCR, MSD, Gyros, and ELISA. In addition, we offer ultra-sensitive immunoassay services with our proprietary Amplatto technology, and advanced functional characterization of biologics with our IntelliB technology.
Sona Nanotech Inc.
Sosna & Co. Inc
Sparx Genomics
Sparz GenomicsQCPartners for your drug discovert, pre-clinical and clinical phaseeloigagnon@sparxgenomics.comWe bring the power of machine learning and human genetics to pinpoint the most promising target-indication pairs.Our GET (Genetic Evidence for Targets) platform allows cost-effective prioritization of target indication pairs more likely to be causal in humans.? Tests over 2000 human diseases, for less than $100K, in less than 2 weeks.
Specific Biologics Inc.Toronto, ONDrug, Therapeuticspecificbiologics.combstead@specificbiologics.comSpecific Biologics is developing Dualase®, an industry-leading genome editing platform with best-in-class accurate editing efficiency, undetectable off-target effects, and true plug-and-play programmability with broad therapeutic potential as in vivo medicines with proof-of-concept in preclinical animal models. Dualase®’s two-site mechanism enables seamless removal, repair and insertion of small or large sequences. Their differentiated pipeline of developments candidates addresses mutations that other genome editors cannot, with an initial focus on repeat expansion disorders in neurodegenerative disease.
SpeciLife
Specktus Pharma IncLaval, QCBiotech& Pharmawww.spektuspharma.comdamonsmith@altusformulation.comSpektus Pharma is a Quebec based specialty pharmaceutical company dedicated to developing innovative therapeutics for the treatment of central nervous system disorders. With a pipeline of value-added specialty medicines and a strong focus on patient-centric solutions, Spektus Pharma is committed to advancing treatments for neurological and psychiatric conditions in collaboration with global manufacturing and commercial partners.
Spectrum Pharma PackagingMontreal, QCBiotech& Pharmawww.spectrumpharma.caeazoulay@spectrumpharma.caSpectrum participates in the growth of the sector by supporting innovative companies by offering unique expertise in clinical trial supply chain management, both nationally and internationally. The services offered include primary and secondary packaging, labeling, warehousing and worldwide distribution of products under investigation in Phase I, II and III. With his FDA and Health Canada licence we are the distribution center of choice in North America and also have a depot in France and Australia to support your projects.
Spektar Pharma IncDrug, Therapeuticspektartx.comcontact@spektartx.comSpektar Therapeutics invests in the licensing, development and commercialization of specialty medicines in the CNS segment.
Spiderwort BiotechnologiesOttawa, ONDrug, Therapeuticspiderwortbio.coms.hanson@spiderwortbio.comSpiderwort is a platform biomaterials company developing a suite of cellulose-based scaffolds for use in a number of regenerative medicine applications. CelluJuve® is being developed as an extended duration dermal filler for aesthetic soft tissue augmentation. CelluBridge®, their solution for spinal cord injury repair, has been granted a breakthrough designation by the FDA after promising preclinical results where it supported regenerating axons leading to locomotor recovery. Spiderwort is extending the CelluBridge® technology to peripheral nerve injury applications and are interested in codeveloping further uses of the biomaterial platform.
St-Amour a divison of Groupe MagellanMontreal, QCSupport Orgs and Associationswww.st-amour.comsriverin@st-amour.comFor 50 years, St-Amour, a division of Magellan Group, has provided specialized recruitment and headhunting services for professionals and executives positions, in Montreal, Toronto and across Canada.
Stereo Biotherapeutics
SteriMax Inc.Oakville, ONDrug, Therapeuticsterimaxinc.combusinessdevelopment@sterimaxinc.com
Stiris Research Inc.London, ONServices: Contract Research, Development, Manufacturingstirisresearch.comshantal@stirisresearch.comStiris is a clinical trial management company conducting Phase I-IIIB trials for biotech and biopharma. Located in Cambridge, MA, USA, and Ontario, Canada, Stiris has a unique opportunity to tap into funding for our non-Canadian clients. It is the only contract research organization formed from listening to stakeholders engaged in clinical trials, identifying their unmet needs, and developing a unique, value-based approach to address those needs. Stiris was built by biotech, for biotech.
Stratford Group
Stratford Intellectual Property
Sussex Research Laboratories Inc.Ottawa, ONServices: Contract Research, Development, Manufacturingsussex-research.comrso@sussex-research.comSussex Research Laboratories Inc. (Ottawa, Canada) is recognized as a leader in the design and synthesis of carbohydrate-based molecules and a trusted partner and CRO to the global R&D community for nearly 30 years. Their deep expertise is applied across a wide range of therapeutic areas, including glycobiology research, drug discovery, targeted drug delivery, vaccine development and protein and antibody engineering. Sussex specializes in cutting-edge glycotechnology solutions that support the development of next-generation therapeutics, whether RNA-based, protein, lipid, Lipid Nano Particle (LNP) or small molecule.
Sustained TherapeuticsBCDrug, Therapeuticsustainedtherapeutics.comwannett@sustainedtx.comSustained Therapeutics is a clinical stage company developing a drug delivery platform technology initially focused on non-opioid pain medication, but extendable to other APIs including significant oncology indications.
SYNG PharmaceuticalsKingston, ONDrug, Therapeuticsyngpharma.comvinay@syngpharma.comSYNG Pharma is developing a new first-in-class diagnostic test and non-hormonal therapy for endometriosis. The company is seeking distributors for its recently launched dual-biomarker endometriosis test and strategic investors or partners for a non-hormonal therapy targeting the treatment of endometriosis. Additional assets available for partnering include a new sepsis test, a digital cognitive assessment and therapy platform for brain and mental health.
Synthory AI
TACTIXOttawa, ONServices: Legal, Consulting, Businesstactix.caalain.madgin@tactix.caTACTIX offers unparalleled experience in solving complex public affairs threats and opportunities in Canada. TACTIX is the exclusive Canadian member of The Advocacy Group (TAG) (https://theadvocacygroup.org), the premier municipal, state, federal and international government and public affairs organization in the world.
Targa BiomedicalMontreal, QCDrug, Therapeutictargabiomedical.comshant.ds@targabiomedical.comTarga Biomedical is a clinically focused biotechnology company that develops innovative solutions for large global unmet needs in transplantation and regenerative medicine.
TATTICA Group
TATUM BioscienceDrug, Therapeutictatumbio.cominfo@tatumbio.comWe are pioneering nanofilament immunotherapy, a radically new therapeutic approach unleashing the true potential of immuno-oncology.
TCG LifeSciences
The Centre for Addiction and Mental Health (CAMH)
The Hospital for Sick ChildrenToronto, ONipc.sickkids.caipc.requests@sickkids.caSickKids is seeking partnerships with biotech, pharmaceutical companies and venture capital investors to advance our innovations through licensing, newco creation or other parnerships.
The Jbl Group
Theranib Inc.Halifax, NShttps://theranib.com/Founded by leading scientists from Dalhousie University in Nova Scotia, Canada, and the University of Pisa, Italy, Theranib combines world-class expertise in molecular cancer biology and medicinal chemistry. Our proprietary compound, CLM296, represents a first-in-class therapeutic innovation designed to enhance the effectiveness of cancer treatments and improve patient outcomes
TheratechnologiesMontreal, QCBiotech& Pharmahttps://www.theratech.complevesque@theratech.comTheratechnologies is a specialty biopharmaceutical company focused on the commercialization of innovative therapies that have the potential to redefine standards of care.
TIAP - Toronto Innovation Acceleration PartnersToronto, ONDrug, Therapeutic,Diagnostics, Device,Digital Healthwww.tiap.capnathwani@tiap.caSince 2008, TIAP has been building relationships with innovators and entrepreneurs at Torontos top universities, hospitals and research institutes to identify the most exciting sparks of ground-breaking therapeutic, medical device and digital health/AI innovation; and then providing the tools, resources, and know-how to transform this work into successful commercial ventures. TIAP's 15-year track record includes the launch of more than 70 new companies, the raising of over $1B in private investment, and the creation of more than 1,000 jobs a measurable impact on the growth of the Ontario life sciences sector and a significant contribution to Canadas economic prosperity.
TLDR Biotech
Toronto Global
Toronto Innovation Acceleration Partners (TIAP)Toronto, ONInvestortiap.caToronto Innovation Acceleration Partners (TIAP) specializes in venture creation and investment in early-stage innovative life sciences technologies emerging from Canada's largest innovation cluster including University of Toronto & 9 affiliated hospitals
TransbiotechLévis, QCSupport Orgs and Associationswww.transbio.techdelphine.davan@tbt.qc.caTransBIOTech is a preclinical research center offering tailored services in biology, pharmacology, and analytical chemistry to support the development of innovative therapeutic solutions – with no waiting list.
TranspharmationFergus, ONServices: Contract Research, Development, Manufacturingtranspharmation.comjoseph.araujo@transpharmation.comTranspharmation is a contract research organisation led by scientists. Recognised by drug developers worldwide for researching and delivering life-changing medicines, science will always remain our passion. Their clients benefit from decades of experience in cross-species and cross-therapeutic area translational biology throughout our preclinical services. Transpharmation has a strong focus on preclinical evaluation of potential CNS therapeutics including the areas of epilepsy, pain, neurodegeneration, depression, anxiety, schizophrenia and cognition.
Treventis CorporationToronto, ONDrug, Therapeutictreventis.comcbarden@treventis.comSmall molecule preclinical company with drugs targeting misfolded proteins in cancer, neurodegeneration and other protein misfolding disorders. Treventis' unique drug design platform against misfolded proteins enables an unexplored disease-modifying drug
Triple HairDrug, Therapeutictriplehair.cainfo@triplehair.caTriple Hair is a biotechnology company developing innovative treatments for alopecia. Triple Hair is attending Bio with the aim of developing partnerships with strategic investors and meeting pharmaceutical companies interested in licensing opportunities.
TVM Life Science Inc.Westmount, QCInvestortvm-lifescience.cominfo@tvm-capital.comTVM Capital Life Science is a dedicated provider of venture capital to the international pharmaceutical, medical technology and healthcare diagnostics industries.
uBriGene Biosciences Inc.
UCB Canada Inc.
Universit Laval - CHUL
University Health NetworkToronto, ONuhncommercialization.cacommercialization@uhn.caUniversity Health Network (UHN) is a globally recognized academic research hospital known for its pioneering scientific discoveries and advanced clinical capabilities. It is the leading medical research commercialization centre in Canada.
University of AlbertaEdmonton, ABAcademicualberta.cadgfast@ualberta.caThe University of Alberta exists to inspire and ignite the human spirit in pursuit of a better tomorrow. Its work is rooted in a commitment to creating a university community where everyone feels valued, barriers to success are removed, and thriving connections are fostered while honouring Indigenous identities, languages, cultures and world views. As one of the world’s top 100 teaching and research universities, the U of A ranks among the top 4 in Canada, providing a $19.4 billion annual economic impact in Alberta alone. The U of A seeks to challenge, to change, and to always be Leading with Purpose.
University of British Columbia
University of CalgaryCalgary, ABAcademicucalgary.camskallos@ucalgary.ca
University of Ottawa
University of TorontoToronto, ONresearch.utoronto.ca
Vaccine and Infectious Disease Organization (VIDO)Saskatoon, SKvido.orgjf.rodriguez@usask.caOriginally established in 1975, we have evolved from a small agricultural focused research organization to a world-class research institute dedicated to the development of vaccines for the protection of human and animal health.
Varian Medical Systems, Inc.
Variational AI Inc.Vancouver, BCDrug, Therapeuticvariational.aihandol@variational.aiGenerative AI platform for drug discovery
VariationalAIVancouver, BCDrug, Therapeutichttps://variational.ai/sree@variational.ai???????????????????Invest Vancouver is Metro Vancouvers regional economic development service.It provides tailored services to help your business grow and expand into the Metro Vancouver region. Our team helps you navigate the regions business landscape by connecting you with key partners, arranging ecosystem tours, and providing assistance in the site selection process. We offer strategic advice, industry insights, and market intelligence to support your investment decisions.
Vasomune Therapeutics, Inc.Toronto, ONDrug, Therapeuticvasomune.comBjahns@vasomune.comVasomune Therapeutics is a private clinical stage biopharmaceutical company that has successfully applied basic research to developing therapeutic assets promoting vascular stabilization.
VeriLuce Therapeutics Inc.Toronto, ONDrug, Therapeuticverilucetherapeutics.comelena.frigerio@verilucetherapeutics.comVeriLuce Therapeutics is an early-stage drug company developing novel small molecules targeting in dual antagonistic mode different chemokine receptors involved in tumor cells growth in certain cancers. The activity of its small molecules involves modulating the Immune Tumor micro-environment with the intent to slow down and/or block tumor cell growth in certain cancers through activation of tumor suppressing immune cells and inactivation of tumor enhancing immune cells. VeriLuce is at the Hit-to-Lead/Lead Optimization stage of development.
Vffice Inc.Longueuil, QCSupport Orgs and Associationswww.vffice.comstilian.nikolow@vffice.comVFFICE is a Microsoft Cloud Solution Partner specializing in Enterprise Software, including ERP, CRM, BI, and Custom Development for the Pharma and Life Sciences Industry. We serve clients globally promoting growth and digital transformation with a dedicated focus on the Microsoft platform and AI.
VIDO- USASK
ViewsMLVancouver, BChttps://www.viewsml.com/ViewsML, a Vancouver-based company, is dedicated to leveraging the power of AI to accelerate the delivery of precision medicines and make them accessible to patients worldwide.
Virano TherapeuticsToronto, ONDrug, Therapeuticviranotx.comella@viranotx.comVirano is a genetic immunomodulation company, developing next-generation combination products which reprogram the immune system to transform the treatment of solid tumors and genetic diseases. Their approach is to rationally combine immune modulating small molecules (VEPOs™) with gene delivery and biological therapeutic elements. Virano creates efficacious therapeutic products to address unmet patient needs through internal development and partnerships.
Virica BiotechOttawa, ONviricabiotech.cominfo@viricabiotech.comVirica is a viral vector enhancer company. We pioneered a production enhancer category called VSE™, small molecules that removes the barriers to manufacturing effective viral medicines at scale.
Virogin Biotech LtdBCDrug, Therapeuticvirogin.comhyzhao@virogin.comVirogin Biotech is a clinical-stage immuno-oncology company, with a primary focus on innovative HSV-1 based oncolytic virotherapy (OV) and RNA-based vaccines to elicit robust and durable anti-tumor immune response against solid tumors.
VoxCell BioInnovationVictoria, BCvoxcellbio.comkvos@voxcellbio.comVoxCell is creating Vascularized Human-like Cancer Tissue Models for Preclinical Tests.
Welch LLP
Western UniversityLondon, ONDrug, Therapeuticuwo.cakplacide@uwo.caAt Western University, ranked within the top 1% of higher education institutions worldwide, we are pioneering a new era in biotechnology and pharmaceutical research. With a community of over 100 specialized neuroscience researchers and 14 Canada Research Chairs, we are pushing boundaries in the treatment and understanding of neurodegenerative diseases.Why Partner with Western University:Neuroscience and Neurodegenerative Disease Research: The TRanslational Initiative to DE-risk NeuroTherapeutics (TRIDENT), bolstered by a $24 million grant from the Government of Canada's New Frontiers in Research program, positions Western at the leading edge of neurodegenerative disease research. TRIDENT's humanized pre-clinical trials, equipped to emulate human clinical studies' complexity, including cognitive assessments and neuroimaging, fast-track the development of neurological treatments from Alzheimer's to Parkinson's and ALS.Clinical and Preclinical Trials: Western's infrastructure is uniquely designed to reflect human clinical trial parameters, facilitating profound exploration and translation of therapies from controlled pre-clinical settings to patient care. Supported by an extensive patient base from three primary hospitals, Western excels in expediting the treatment lifecycle, from research to market.Oncology Research and Development: Our oncology research complements our neuroscience expertise, with researchers engaged from fundamental molecular science to translational oncology trials. Our work in developing cancer treatments and personalized medicine is enhanced by our focus on theranostics, integrating therapy with diagnostics for precise, targeted interventions.Molecular Imaging and Theranostics: The CFMM houses Canada's exclusive high-field and ultra-high field MRI systems, including an innovative 15.2 Tesla MRI, solidifying our lead in neuroimaging and theranostics. This unique combination propels personalized medicine, offering targeted treatments based on detailed diagnostics.From Laboratory to Lifesaving Therapies:Our collaborative ecosystem, boasting advanced imaging technology and strong hospital partnerships, sets the stage for impactful translational research. Our commitment is to ensure that our scientific discoveries lead to improved health outcomes, supporting the full spectrum from molecular research to patient treatment.An Invitation to Action:We call on the biotech and pharma industries to explore partnership opportunities with Western University. Join us as we transform visionary ideas into life-enhancing realities. Let's engage in discussions on how our partnership can open new avenues and accelerate healthcare innovation. Connect with us to shape the future of medicine, driving forward from groundbreaking research to the development of next-generation treatments. Together, at Western University, your goals for progress and impact can find a collaborative and dynamic environment.
World Courier, part of the Cencora familyRichmond, BCProfessional Services www.worldcourier.combrian.jobling@worldcourier.comWorld Courier, part of the Cencora family of companies, provides specialty logistics services to drive the clinical and commercial success of our partners around the globe. We deliver peace of mind through world-class supply chain programs, transport services, decentralized clinical trial support, and storage for time- and temperature-sensitive products, including innovative medicines like cell and gene therapies. Fueled by over 4,000 dedicated members, we operate an extensive specialty logistics network that spans more than 120 company-owned facilities across over 50 countries.
World Trade Centre WinnipegWinnipeg, MBNon-Profit, Industry Association, Incubatorhttps://www.wtcwinnipeg.com/abrin@wtcwinnipeg.comThe World Trade Centre Winnpeg ia an information hub for Manitoba entrepreneurs. As a member of the World Trade Centers Association (WTCA) and theb Western Canada Business Service Network(WCBSN), we are focused on Business growth at every stage-from starting up to expanding into international markets. Whether you're launching a new business, looking to grow in Manitoba or exploring export opportunities, we're here to help. Our team offers one-on-one advisory services, tailored market research, and around -the-clockaccess to business resources. We provide flexible seminars and workshops, facilitates local and international networking, and connect you to new opportunities through programs like Trade accelerator program and connectors' club. Our goal is to help you find new solutions, reach new markets and succeed
XEDITON PHARMACEUTICALS INC.Mississauga, ONDrug, Therapeuticxediton.cominfo@xediton.comXediton Pharmaceuticals is a privately-held Specialty Pharma company with a focus on meeting the needs of patients, physicians and partners. We are located in the Greater Toronto Area, Ontario, Canada.
Xenon Pharmaceuticals, IncBurnaby, BCDrug, Therapeuticxenon-pharma.cominfo@xenon-pharma.comXenon Pharmaceuticals (NASDAQ:XENE) is a clinical stage biopharmaceutical company committed to developing innovative therapeutics to improve the lives of patients with neurological disorders.
York University
YYZ Pharmatech Inc.Toronto, ONDiagnostics, Deviceyyzpharmatech.commbadeau@yyzpharmatech.comYYZ Pharmatech Inc. (“YYZ”) is a deep tech company endeavoring to profoundly progress new medicine for patients by revealing the plasma proteome. Plasma is notoriously complex but contains the most biologically relevant proteins and peptides when derived from human patients. YYZ has pioneered technologies to discover, validate and assay the most elusive low-abundance proteins and peptides. This unprecedented lens into the plasma proteome unlocks new fluid biomarkers, attractive cell-surface co-receptor drug targets, and highly-specific biomolecules. YYZ’s key objective is to identify world-class pharma collaborators to progress multi-specific antibody and peptide therapies against novel cell-surface co-receptor drug targets discovered by YYZ in oncology, immunology and metabolic disorders.
Zymewire
Zymeworks Inc.Vancouver, BCDrug, Therapeuticzymeworks.cominfo@zymeworks.comZymeworks (Nasdaq: ZYME) is a global biotechnology company committed to the discovery, development, and commercialization of novel, multifunctional biotherapeutics.